Wing-ho Yung - Publications

Affiliations: 
The Chinese University of Hong Kong, Hong Kong, Hong Kong 
Area:
Synaptic Transmission/Nervous System Dysfunction

81/396 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Zhang F, Mak SOK, Liu Y, Ke Y, Rao F, Yung WH, Zhang L, Chow BKC. Secretin receptor deletion in the subfornical organ attenuates the activation of excitatory neurons under dehydration. Current Biology : Cb. PMID 36220076 DOI: 10.1016/j.cub.2022.09.037  0.308
2022 Xu L, Li Q, Ke Y, Yung WH. Chronic Intermittent Hypoxia-Induced Aberrant Neural Activities in the Hippocampus of Male Rats Revealed by Long-Term Recording. Frontiers in Cellular Neuroscience. 15: 784045. PMID 35126057 DOI: 10.3389/fncel.2021.784045  0.342
2020 Zhao J, Fok AHK, Fan R, Kwan PY, Chan HL, Lo LH, Chan YS, Yung WH, Huang J, Lai CSW, Lai KO. Specific depletion of the motor protein KIF5B leads to deficits in dendritic transport, synaptic plasticity and memory. Elife. 9. PMID 31961321 DOI: 10.7554/Elife.53456  0.312
2019 Lin R, Duan Z, Sun H, Fung ML, Chen H, Wang J, Lau CF, Yang D, Liu Y, Ni Y, Wang Z, Cui J, Wu W, Yung WH, Chan YS, et al. Kinesin-1 Regulates Extrasynaptic Targeting of NMDARs and Neuronal Vulnerability Toward Excitotoxicity. Iscience. 13: 82-97. PMID 30826728 DOI: 10.1016/J.Isci.2019.02.009  0.376
2018 Dukhinova M, Kuznetsova I, Kopeykina E, Veniaminova E, Yung AWY, Veremeyko T, Levchuk K, Barteneva NS, Ho KKW, Yung WH, Liu JYH, Rudd J, Yau SSY, Anthony DC, Strekalova T, et al. Platelets mediate protective neuroinflammation and promote neuronal plasticity at the site of neuronal injury. Brain, Behavior, and Immunity. PMID 30217533 DOI: 10.1016/J.Bbi.2018.09.009  0.352
2018 Cui Q, Li Q, Geng H, Chen L, Ip NY, Ke Y, Yung WH. Dopamine receptors mediate strategy abandoning via modulation of a specific prelimbic cortex-nucleus accumbens pathway in mice. Proceedings of the National Academy of Sciences of the United States of America. PMID 29735678 DOI: 10.1073/Pnas.1717106115  0.673
2018 Zhuang QX, Xu HT, Lu XJ, Li B, Yung WH, Wang JJ, Zhu JN. Histamine Excites Striatal Dopamine D1 and D2 Receptor-Expressing Neurons via Postsynaptic H1 and H2 Receptors. Molecular Neurobiology. PMID 29498008 DOI: 10.1007/s12035-018-0976-1  0.387
2017 Hao R, Qi Y, Hou DN, Ji YY, Zheng CY, Li CY, Yung WH, Lu B, Huang Y. BDNF val66met Polymorphism Impairs Hippocampal Long-Term Depression by Down-Regulation of 5-HT3 Receptors. Frontiers in Cellular Neuroscience. 11: 306. PMID 29075179 DOI: 10.3389/fncel.2017.00306  0.343
2017 Li Q, Ko H, Qian ZM, Yan LYC, Chan DCW, Arbuthnott G, Ke Y, Yung WH. Refinement of learned skilled movement representation in motor cortex deep output layer. Nature Communications. 8: 15834. PMID 28598433 DOI: 10.1038/Ncomms15834  0.509
2017 Wu XM, Qian C, Zhou YF, Yan YC, Luo QQ, Yung WH, Zhang FL, Jiang LR, Qian ZM, Ke Y. Bi-directionally protective communication between neurons and astrocytes under ischemia. Redox Biology. 13: 20-31. PMID 28551085 DOI: 10.1016/J.Redox.2017.05.010  0.349
2016 Leong AT, Chan RW, Gao PP, Chan YS, Tsia KK, Yung WH, Wu EX. Long-range projections coordinate distributed brain-wide neural activity with a specific spatiotemporal profile. Proceedings of the National Academy of Sciences of the United States of America. PMID 27930323 DOI: 10.1073/Pnas.1616361113  0.325
2015 Chen L, Xu R, Sun FJ, Xue Y, Hao XM, Liu HX, Wang H, Chen XY, Liu ZR, Deng WS, Han XH, Xie JX, Yung WH. Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels regulate firing of globus pallidus neurons in vivo. Molecular and Cellular Neurosciences. 68: 46-55. PMID 25858108 DOI: 10.1016/J.Mcn.2015.04.001  0.455
2015 Zhang J, Zhuang QX, Li B, Wu GY, Yung WH, Zhu JN, Wang JJ. Selective Modulation of Histaminergic Inputs on Projection Neurons of Cerebellum Rapidly Promotes Motor Coordination via HCN Channels. Molecular Neurobiology. PMID 25633097 DOI: 10.1007/s12035-015-9096-3  0.378
2014 Fang WQ, Chen WW, Jiang L, Liu K, Yung WH, Fu AK, Ip NY. Overproduction of upper-layer neurons in the neocortex leads to autism-like features in mice. Cell Reports. 9: 1635-43. PMID 25466248 DOI: 10.1016/J.Celrep.2014.11.003  0.371
2014 Huang Y, Yoon K, Ko H, Jiao S, Ito W, Wu JY, Yung WH, Lu B, Morozov A. 5-HT3a Receptors Modulate Hippocampal Gamma Oscillations by Regulating Synchrony of Parvalbumin-Positive Interneurons. Cerebral Cortex (New York, N.Y. : 1991). PMID 25246509 DOI: 10.1093/Cercor/Bhu209  0.529
2014 Tang J, Ip JP, Ye T, Ng YP, Yung WH, Wu Z, Fang W, Fu AK, Ip NY. Cdk5-dependent Mst3 phosphorylation and activity regulate neuronal migration through RhoA inhibition. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 34: 7425-36. PMID 24872548 DOI: 10.1523/Jneurosci.5449-13.2014  0.345
2014 Qian ZM, He X, Liang T, Wu KC, Yan YC, Lu LN, Yang G, Luo QQ, Yung WH, Ke Y. Lipopolysaccharides upregulate hepcidin in neuron via microglia and the IL-6/STAT3 signaling pathway. Molecular Neurobiology. 50: 811-20. PMID 24659348 DOI: 10.1007/S12035-014-8671-3  0.309
2014 Li Q, Qian ZM, Arbuthnott GW, Ke Y, Yung WH. Cortical effects of deep brain stimulation: implications for pathogenesis and treatment of Parkinson disease. Jama Neurology. 71: 100-3. PMID 24189904 DOI: 10.1001/Jamaneurol.2013.4221  0.373
2013 Sun XR, Chen L, Chen WF, Xue Y, Yung WH. Electrophysiological and behavioral effects of group III metabotropic glutamate receptors on pallidal neurons in normal and parkinsonian rats. Synapse (New York, N.Y.). 67: 831-8. PMID 23813476 DOI: 10.1002/Syn.21694  0.491
2013 Huang Y, Wang JJ, Yung WH. Coupling between GABA-A receptor and chloride transporter underlies ionic plasticity in cerebellar Purkinje neurons. Cerebellum (London, England). 12: 328-30. PMID 23341142 DOI: 10.1007/s12311-013-0453-3  0.415
2012 Zhang XH, Ma ZG, Rowlands DK, Gou YL, Fok KL, Wong HY, Yu MK, Tsang LL, Mu L, Chen L, Yung WH, Chung YW, Zhang BL, Zhao H, Chan HC. Flavonoid Myricetin Modulates GABA(A) Receptor Activity through Activation of Ca(2+) Channels and CaMK-II Pathway. Evidence-Based Complementary and Alternative Medicine : Ecam. 2012: 758097. PMID 23258999 DOI: 10.1155/2012/758097  0.427
2012 Li Q, Ke Y, Chan DC, Qian ZM, Yung KK, Ko H, Arbuthnott GW, Yung WH. Therapeutic deep brain stimulation in Parkinsonian rats directly influences motor cortex. Neuron. 76: 1030-41. PMID 23217750 DOI: 10.1016/J.Neuron.2012.09.032  0.556
2012 Sun XR, Chen L, Chen WF, Yung WH. Electrophysiological and behavioral effects of group I metabotropic glutamate receptors on pallidal neurons in rats. Brain Research. 1477: 1-9. PMID 22940610 DOI: 10.1016/J.Brainres.2012.08.027  0.508
2012 Huang Y, Ko H, Cheung ZH, Yung KK, Yao T, Wang JJ, Morozov A, Ke Y, Ip NY, Yung WH. Dual actions of brain-derived neurotrophic factor on GABAergic transmission in cerebellar Purkinje neurons. Experimental Neurology. 233: 791-8. PMID 22178325 DOI: 10.1016/J.Expneurol.2011.11.043  0.567
2012 Ip JP, Shi L, Chen Y, Itoh Y, Fu WY, Betz A, Yung WH, Gotoh Y, Fu AK, Ip NY. α2-chimaerin controls neuronal migration and functioning of the cerebral cortex through CRMP-2. Nature Neuroscience. 15: 39-47. PMID 22138645 DOI: 10.1038/Nn.2972  0.351
2012 Wu GY, Han XH, Zhuang QX, Zhang J, Yung WH, Chan YS, Zhu JN, Wang JJ. Excitatory effect of histamine on rat spinal motoneurons by activation of both H₁ and Hâ‚‚ receptors in vitro. Journal of Neuroscience Research. 90: 132-42. PMID 21922515 DOI: 10.1002/Jnr.22730  0.338
2011 Li ZW, Liu S, Weinreb RN, Lindsey JD, Yu M, Liu L, Ye C, Cui Q, Yung WH, Pang CP, Lam DS, Leung CK. Tracking dendritic shrinkage of retinal ganglion cells after acute elevation of intraocular pressure. Investigative Ophthalmology & Visual Science. 52: 7205-12. PMID 21775662 DOI: 10.1167/Iovs.10-6868  0.554
2011 Wu XM, Qian ZM, Zhu L, Du F, Yung WH, Gong Q, Ke Y. Neuroprotective effect of ligustilide against ischaemia-reperfusion injury via up-regulation of erythropoietin and down-regulation of RTP801. British Journal of Pharmacology. 164: 332-43. PMID 21410687 DOI: 10.1111/J.1476-5381.2011.01337.X  0.326
2011 Li Q, Ke Y, Yung W. Alleviation of parkinsonian motor symptoms by deep brain stimulation: Involvement of the antidromic response through the “hyperdirec” pathway Neuroscience Research. 71: e192. DOI: 10.1016/J.Neures.2011.07.829  0.329
2010 Xie H, Leung KL, Chen L, Chan YS, Ng PC, Fok TF, Wing YK, Ke Y, Li AM, Yung WH. Brain-derived neurotrophic factor rescues and prevents chronic intermittent hypoxia-induced impairment of hippocampal long-term synaptic plasticity. Neurobiology of Disease. 40: 155-62. PMID 20553872 DOI: 10.1016/J.Nbd.2010.05.020  0.344
2010 Zhang SJ, Wang H, Xue Y, Yung WH, Chen L. Behavioral and electrophysiological effects of 5-HT in globus pallidus of 6-hydroxydopamine lesioned rats. Journal of Neuroscience Research. 88: 1549-56. PMID 20029979 DOI: 10.1002/Jnr.22325  0.438
2010 Li Q, Zhang S, Yung W, Zheng X. Mechanisms underlying locomotor asymmetry in the rat induced by stimulation of the medial forebrain bundle Neuroscience Research. 68: e193-e194. DOI: 10.1016/J.Neures.2010.07.2428  0.359
2009 Chen L, Cui QL, Yung WH. Neurokinin-1 receptor activation in globus pallidus. Frontiers in Neuroscience. 3: 58. PMID 20582283 DOI: 10.3389/Neuro.23.002.2009  0.693
2009 Chu JY, Lee LT, Lai CH, Vaudry H, Chan YS, Yung WH, Chow BK. Secretin as a neurohypophysial factor regulating body water homeostasis. Proceedings of the National Academy of Sciences of the United States of America. 106: 15961-6. PMID 19805236 DOI: 10.1073/pnas.0903695106  0.63
2009 Du F, Qian ZM, Zhu L, Wu XM, Yung WH, Tsim TY, Ke Y. L-DOPA neurotoxicity is mediated by up-regulation of DMT1-IRE expression. Plos One. 4: e4593. PMID 19240805 DOI: 10.1371/Journal.Pone.0004593  0.331
2009 Xue Y, Bai B, Yung WH, Chen L. Electrophysiological effects of neurotensin on globus pallidus neurons of 6-hydroxydopamine-lesioned rats. Neuro-Signals. 17: 153-61. PMID 19202346 DOI: 10.1159/000199047  0.48
2008 Zhang LL, Chen L, Xue Y, Yung WH. Modulation of synaptic GABAA receptor function by zolpidem in substantia nigra pars reticulata. Acta Pharmacologica Sinica. 29: 161-8. PMID 18215344 DOI: 10.1111/J.1745-7254.2008.00735.X  0.498
2008 Chen L, Yung KK, Chan YS, Yung WH. 5-HT excites globus pallidus neurons by multiple receptor mechanisms. Neuroscience. 151: 439-51. PMID 18082329 DOI: 10.1016/J.Neuroscience.2007.11.003  0.411
2008 Cui QL, Yung WH, Chen L. Effects of substance P on neuronal firing of pallidal neurons in parkinsonian rats. Neuroscience Research. 60: 162-9. PMID 18054402 DOI: 10.1016/J.Neures.2007.10.007  0.679
2007 Cui QL, Yung WH, Xue Y, Chen L. Substance P excites globus pallidus neurons in vivo. The European Journal of Neuroscience. 26: 1853-61. PMID 17868370 DOI: 10.1111/J.1460-9568.2007.05803.X  0.668
2007 Chen H, Chen L, Wang JJ, Wei HJ, Yung WH. Distribution and electrophysiological effects of motilin in Purkinje cells. Neuroreport. 18: 1345-9. PMID 17762710 DOI: 10.1097/Wnr.0B013E328273Bc98  0.44
2007 Ho SS, Chow BK, Yung WH. Serotonin increases the excitability of the hypothalamic paraventricular nucleus magnocellular neurons. The European Journal of Neuroscience. 25: 2991-3000. PMID 17561813 DOI: 10.1111/j.1460-9568.2007.05547.x  0.745
2007 Xue Y, Chen L, Cui QL, Xie JX, Yung WH. Electrophysiological and behavioral effects of neurotensin in rat globus pallidus: an in vivo study. Experimental Neurology. 205: 108-15. PMID 17362935 DOI: 10.1016/J.Expneurol.2007.01.031  0.701
2007 Chen L, Xie JX, Fung KS, Yung WH. Zolpidem modulates GABA(A) receptor function in subthalamic nucleus. Neuroscience Research. 58: 77-85. PMID 17337310 DOI: 10.1016/J.Neures.2007.02.002  0.503
2007 Fu WY, Chen Y, Sahin M, Zhao XS, Shi L, Bikoff JB, Lai KO, Yung WH, Fu AK, Greenberg ME, Ip NY. Cdk5 regulates EphA4-mediated dendritic spine retraction through an ephexin1-dependent mechanism. Nature Neuroscience. 10: 67-76. PMID 17143272 DOI: 10.1038/Nn1811  0.3
2006 Chen L, Yung WH. Zinc modulates GABAergic neurotransmission in rat globus pallidus. Neuroscience Letters. 409: 163-7. PMID 17046159 DOI: 10.1016/J.Neulet.2006.09.033  0.531
2006 Chu JY, Yung WH, Chow BK. Endogenous release of secretin from the hypothalamus. Annals of the New York Academy of Sciences. 1070: 196-200. PMID 16888165 DOI: 10.1196/annals.1317.012  0.636
2006 Chu JY, Yung WH, Chow BK. Secretin: a pleiotrophic hormone. Annals of the New York Academy of Sciences. 1070: 27-50. PMID 16888148 DOI: 10.1196/annals.1317.013  0.626
2006 Chen L, Yung KK, Yung WH. Neurotensin selectively facilitates glutamatergic transmission in globus pallidus. Neuroscience. 141: 1871-8. PMID 16814931 DOI: 10.1016/J.Neuroscience.2006.05.049  0.464
2006 Yung WH, Chan YS, Chow BK, Wang JJ. The role of secretin in the cerebellum. Cerebellum (London, England). 5: 43-8. PMID 16527763 DOI: 10.1080/14734220500416829  0.681
2006 Jin W, Ge WP, Xu J, Cao M, Peng L, Yung W, Liao D, Duan S, Zhang M, Xia J. Lipid binding regulates synaptic targeting of PICK1, AMPA receptor trafficking, and synaptic plasticity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 2380-90. PMID 16510715 DOI: 10.1523/Jneurosci.3503-05.2006  0.323
2006 Zhu JN, Yung WH, Kwok-Chong Chow B, Chan YS, Wang JJ. The cerebellar-hypothalamic circuits: potential pathways underlying cerebellar involvement in somatic-visceral integration. Brain Research Reviews. 52: 93-106. PMID 16497381 DOI: 10.1016/J.Brainresrev.2006.01.003  0.313
2006 Yung W, Johnson EE, Christie MJ, Connor M, Yao X, Kwan H, Huang Y, Yung WH, Lui PW, Yeung CW, Shi Y, Chen LW, Chan YS, Yung KKL, Ioja E, et al. Subject Index Vol. 14, 2005 Neurosignals. 14: 330-330. DOI: 10.1159/000093977  0.439
2005 Chan CS, Surmeier DJ, Yung WH. Striatal information signaling and integration in globus pallidus: timing matters. Neuro-Signals. 14: 281-9. PMID 16772731 DOI: 10.1159/000093043  0.726
2005 Chen K, Wang JJ, Yung WH, Chan YS, Chow BK. Excitatory effect of histamine on neuronal activity of rat globus pallidus by activation of H2 receptors in vitro. Neuroscience Research. 53: 288-97. PMID 16143415 DOI: 10.1016/j.neures.2005.07.008  0.669
2005 Lee SM, Chen L, Chow BK, Yung WH. Endogenous release and multiple actions of secretin in the rat cerebellum. Neuroscience. 134: 377-86. PMID 15963647 DOI: 10.1016/J.Neuroscience.2005.04.009  0.713
2005 Lee SM, Yung WH, Chen L, Chow BK. Expression and spatial distribution of secretin and secretin receptor in human cerebellum. Neuroreport. 16: 219-22. PMID 15706223 DOI: 10.1097/00001756-200502280-00003  0.677
2005 Chen L, Yung WH. Tonic activation of presynaptic GABA(B) receptors on rat pallidosubthalamic terminals. Acta Pharmacologica Sinica. 26: 10-6. PMID 15659108 DOI: 10.1111/J.1745-7254.2005.00012.X  0.507
2005 Yung W, Johnson EE, Christie MJ, Connor M, Yao X, Kwan H, Huang Y, Yung WH, Lui PW, Yeung CW, Shi Y, Chen LW, Chan YS, Yung KKL, Ioja E, et al. Contents Vol. 14, 2005 Neurosignals. 14: 331-332. DOI: 10.1159/000093978  0.449
2005 Lai S, Yung W, Chan Y. Developmental profile of ionotropic glutamate receptors in spinal vestibular neurons of rats Neuroscience Research. DOI: 10.1016/J.Neures.2005.04.001  0.376
2004 Pang PT, Teng HK, Zaitsev E, Woo NT, Sakata K, Zhen S, Teng KK, Yung WH, Hempstead BL, Lu B. Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science (New York, N.Y.). 306: 487-91. PMID 15486301 DOI: 10.1126/Science.1100135  0.738
2004 Chen L, Yung WH. GABAergic neurotransmission in globus pallidus and its involvement in neurologic disorders. Sheng Li Xue Bao : [Acta Physiologica Sinica]. 56: 427-35. PMID 15322674  0.409
2004 Chen L, Boyes J, Yung WH, Bolam JP. Subcellular localization of GABAB receptor subunits in rat globus pallidus. The Journal of Comparative Neurology. 474: 340-52. PMID 15174078 DOI: 10.1002/Cne.20143  0.434
2004 Chen L, Chan YS, Yung WH. GABA-B receptor activation in the rat globus pallidus potently suppresses pentylenetetrazol-induced tonic seizures. Journal of Biomedical Science. 11: 457-64. PMID 15153780 DOI: 10.1007/Bf02256094  0.456
2004 Chen L, Yung KK, Yung WH. Neurotensin depolarizes globus pallidus neurons in rats via neurotensin type-1 receptor. Neuroscience. 125: 853-9. PMID 15120846 DOI: 10.1016/J.Neuroscience.2004.02.031  0.485
2004 Chen L, Savio Chan C, Yung WH. Electrophysiological and behavioral effects of zolpidem in rat globus pallidus. Experimental Neurology. 186: 212-20. PMID 15026257 DOI: 10.1016/J.Expneurol.2003.11.003  0.425
2004 Pang RT, Lee LT, Ng SS, Yung WH, Chow BK. CpG methylation and transcription factors Sp1 and Sp3 regulate the expression of the human secretin receptor gene. Molecular Endocrinology (Baltimore, Md.). 18: 471-83. PMID 14645499 DOI: 10.1210/me.2003-0245  0.633
2003 Chen L, Yung WH. Effects of the GABA-uptake inhibitor tiagabine in rat globus pallidus. Experimental Brain Research. 152: 263-9. PMID 12879169 DOI: 10.1007/S00221-003-1549-7  0.5
2002 Ng SS, Yung WH, Chow BK. Secretin as a neuropeptide. Molecular Neurobiology. 26: 97-107. PMID 12392059 DOI: 10.1385/MN:26:1:097  0.669
2002 Chen L, Chan SC, Yung WH. Rotational behavior and electrophysiological effects induced by GABA(B) receptor activation in rat globus pallidus. Neuroscience. 114: 417-25. PMID 12204211 DOI: 10.1016/S0306-4522(02)00299-3  0.452
2001 Yung WH, Leung PS, Ng SS, Zhang J, Chan SC, Chow BK. Secretin facilitates GABA transmission in the cerebellum. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 7063-8. PMID 11549716 DOI: 10.1523/Jneurosci.21-18-07063.2001  0.666
2001 Ng SS, Yu KL, Yung WH, Chow BK. Real-time analysis of the activities of GnRH and GnRH analogs in alphaT3-1 cells by the Cytosensor microphysiometer. Journal of Cellular Biochemistry. 80: 304-12. PMID 11135359 DOI: 10.1002/1097-4644(20010301)80:3<304::AID-JCB20>3.0.CO;2-H  0.625
1999 Chan PKY, Yung WH. Inhibitory postsynaptic currents of rat substantia nigra pars reticulata neurons: Role of GABA receptors and GABA uptake Brain Research. 838: 18-26. PMID 10446312 DOI: 10.1016/S0006-8993(99)01654-6  0.403
1998 Chan PKY, Yung WH. Occlusion of the presynaptic action of cannabinoids in rat substantia nigra pars reticulata by cadmium Neuroscience Letters. 249: 57-60. PMID 9672388 DOI: 10.1016/S0304-3940(98)00396-6  0.432
1998 Chan PKY, Leung CKS, Yung WH. Differential expression of pre- and postsynaptic GABA(B) receptors in rat substantia nigra pars reticulata neurones European Journal of Pharmacology. 349: 187-197. PMID 9671097 DOI: 10.1016/S0014-2999(98)00194-0  0.428
1998 Chan PKY, Chan SCY, Yung WH. Presynaptic inhibition of GABAergic inputs to rat substantia nigra pars reticulata neurones by a cannabinoid agonist Neuroreport. 9: 671-675. PMID 9559936  0.35
1997 Ye GL, Tse ACO, Yung WH. Taurine inhibits rat substantia nigra pars reticulata neurons by activation of GABA- and glycine-linked chloride conductance Brain Research. 749: 175-179. PMID 9070647 DOI: 10.1016/S0006-8993(96)01427-8  0.392
1996 Wu CW, Leung CKS, Yung WH. Sulphonylureas reverse hypoxia induced K+-conductance increase in substantia nigra pars reticulata neurones Neuroreport. 7: 2513-2517. PMID 8981414 DOI: 10.1097/00001756-199611040-00022  0.367
1994 Häusser MA, Yung WH. Inhibitory synaptic potentials in guinea-pig substantia nigra dopamine neurones in vitro. The Journal of Physiology. 479: 401-22. PMID 7837097  0.609
1992 Häusser MA, Yung WH, Lacey MG. Taurine and glycine activate the same Cl- conductance in substantia nigra dopamine neurones. Brain Research. 571: 103-8. PMID 1611483 DOI: 10.1016/0006-8993(92)90514-A  0.582
1991 Yung WH, Häusser MA, Jack JJ. Electrophysiology of dopaminergic and non-dopaminergic neurones of the guinea-pig substantia nigra pars compacta in vitro. The Journal of Physiology. 436: 643-67. PMID 2061849  0.677
Low-probability matches (unlikely to be authored by this person)
2013 He YY, Zhang XY, Yung WH, Zhu JN, Wang JJ. Role of BDNF in central motor structures and motor diseases. Molecular Neurobiology. 48: 783-93. PMID 23649659 DOI: 10.1007/s12035-013-8466-y  0.299
2017 Hao R, Qi Y, Hou DN, Ji YY, Zheng CY, Li CY, Yung WH, Lu B, Huang Y. Corrigendum: BDNF val66met Polymorphism Impairs Hippocampal Long-Term Depression by Down-Regulation of 5-HT3 Receptors. Frontiers in Cellular Neuroscience. 11: 351. PMID 29219152 DOI: 10.3389/fncel.2017.00351  0.298
1997 Ye GL, Leung CKS, Yung WH. Pre-synaptic effect of the ATP-sensitive potassium channel opener diazoxide on rat substantia nigra pars reticulata neurons Brain Research. 753: 1-7. PMID 9125425 DOI: 10.1016/S0006-8993(96)01473-4  0.297
2010 Xie H, Leung K, Li AM, Yung W. Chronic intermittent hypoxia impairs synaptic plasticity and expression of brain-derived neurotrophic factor in mouse hippocampus Neuroscience Research. 68. DOI: 10.1016/J.Neures.2010.07.2345  0.296
2010 Shi L, Butt B, Ip FC, Dai Y, Jiang L, Yung WH, Greenberg ME, Fu AK, Ip NY. Ephexin1 is required for structural maturation and neurotransmission at the neuromuscular junction. Neuron. 65: 204-16. PMID 20152127 DOI: 10.1016/J.Neuron.2010.01.012  0.296
2012 Xie H, Yung WH. Chronic intermittent hypoxia-induced deficits in synaptic plasticity and neurocognitive functions: a role for brain-derived neurotrophic factor. Acta Pharmacologica Sinica. 33: 5-10. PMID 22212429 DOI: 10.1038/aps.2011.184  0.295
2018 Ni YX, Zhou N, Xue WQ, Rong L, Yung WH, Lin RZ, Kao RY, Duan ZG, Sun HT, Gong HR, Tang XM, Liu MF, Zhang W, Qi S, Chung S, et al. A new role of anterograde motor Kif5b in facilitating large clathrin-coated vesicle mediated endocytosis via regulating clathrin uncoating. Cell Discovery. 4: 65. PMID 30603101 DOI: 10.1038/S41421-018-0067-5  0.293
2005 Fu AK, Ip FC, Fu WY, Cheung J, Wang JH, Yung WH, Ip NY. Aberrant motor axon projection, acetylcholine receptor clustering, and neurotransmission in cyclin-dependent kinase 5 null mice. Proceedings of the National Academy of Sciences of the United States of America. 102: 15224-9. PMID 16203963 DOI: 10.1073/pnas.0507678102  0.286
1996 Baumann KI, Chan E, Halata Z, Senok SS, Yung WH. An isolated rat vibrissal preparation with stable responses of slowly adapting mechanoreceptors Neuroscience Letters. 213: 1-4. PMID 8844698 DOI: 10.1016/0304-3940(96)12813-5  0.285
2012 Lai KO, Wong AS, Cheung MC, Xu P, Liang Z, Lok KC, Xie H, Palko ME, Yung WH, Tessarollo L, Cheung ZH, Ip NY. TrkB phosphorylation by Cdk5 is required for activity-dependent structural plasticity and spatial memory. Nature Neuroscience. 15: 1506-15. PMID 23064382 DOI: 10.1038/nn.3237  0.284
2012 Lui NP, Chen LW, Yung WH, Chan YS, Yung KK. Endogenous repair by the activation of cell survival signalling cascades during the early stages of rat Parkinsonism. Plos One. 7: e51294. PMID 23251488 DOI: 10.1371/Journal.Pone.0051294  0.281
2022 Xue WX, Li QX, Zhang YX, Zhang XY, Yung WH, Wang JJ, Zhu JN. [Changes in sensitivity of bilateral medial vestibular nuclear neurons responding to input stimuli during vestibular compensation and the underlying ionic mechanism]. Sheng Li Xue Bao : [Acta Physiologica Sinica]. 74: 135-144. PMID 35503061  0.281
2005 Lui PW, Yeung CW, Yung WH, Shi Y, Chen LW, Chan YS, Yung KK. Ablation of gene expression of N-methyl-D-aspartate receptor one by antisense oligonucleotides in striatal neurons in culture. Neuro-Signals. 14: 303-16. PMID 16772733 DOI: 10.1159/000093045  0.277
2019 Li C, Chan DCW, Yang X, Ke Y, Yung WH. Prediction of Forelimb Reach Results From Motor Cortex Activities Based on Calcium Imaging and Deep Learning. Frontiers in Cellular Neuroscience. 13: 88. PMID 30914924 DOI: 10.3389/Fncel.2019.00088  0.276
2014 Huang XT, Qian ZM, He X, Gong Q, Wu KC, Jiang LR, Lu LN, Zhu ZJ, Zhang HY, Yung WH, Ke Y. Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease. Neurobiology of Aging. 35: 1045-54. PMID 24332448 DOI: 10.1016/J.Neurobiolaging.2013.11.004  0.276
2020 Zhao J, Fok AHK, Fan R, Kwan P, Chan H, Lo LH, Chan Y, Yung W, Huang J, Lai CSW, Lai K. Author response: Specific depletion of the motor protein KIF5B leads to deficits in dendritic transport, synaptic plasticity and memory Elife. DOI: 10.7554/Elife.53456.Sa2  0.275
2014 Yu Y, Cao DQ, Xu HY, Sun M, Huang ZL, Yung WH, Lu N, Huang Y. 5-HT3A receptors are required in long-term depression and AMPA receptor internalization. Neuroscience. 278: 105-12. PMID 25130560 DOI: 10.1016/j.neuroscience.2014.07.070  0.274
2012 Ke Y, Chan Y, Yung W. Mechanism of chronic intermittent hypoxia-induced impairment in synaptic plasticity and neurocognitive dysfunction Science. DOI: 10.1126/Science.338.6113.1485-C  0.273
2016 Lu LN, Qian ZM, Wu KC, Yung WH, Ke Y. Expression of Iron Transporters and Pathological Hallmarks of Parkinson's and Alzheimer's Diseases in the Brain of Young, Adult, and Aged Rats. Molecular Neurobiology. PMID 27578012 DOI: 10.1007/S12035-016-0067-0  0.27
2003 Lui PW, Suen KC, Chan YS, Yung WH, Yung KK. Striatal neurons but not nigral dopaminergic neurons in neonatal primary cell culture express endogenous functional N-methyl-D-aspartate receptors. Brain Research. Molecular Brain Research. 120: 9-21. PMID 14667572 DOI: 10.1016/j.molbrainres.2003.09.015  0.268
2015 Xu LH, Xie H, Shi ZH, Du LD, Wing YK, Li AM, Ke Y, Yung WH. Critical Role of Endoplasmic Reticulum Stress in Chronic Intermittent Hypoxia-Induced Deficits in Synaptic Plasticity and Long-Term Memory. Antioxidants & Redox Signaling. PMID 25843188 DOI: 10.1089/Ars.2014.6122  0.268
2011 Du F, Qian C, Qian ZM, Wu XM, Xie H, Yung WH, Ke Y. Hepcidin directly inhibits transferrin receptor 1 expression in astrocytes via a cyclic AMP-protein kinase A pathway. Glia. 59: 936-45. PMID 21438013 DOI: 10.1002/Glia.21166  0.267
2016 Zeng M, Shang Y, Guo T, He Q, Yung WH, Liu K, Zhang M. A binding site outside the canonical PDZ domain determines the specific interaction between Shank and SAPAP and their function. Proceedings of the National Academy of Sciences of the United States of America. PMID 27185935 DOI: 10.1073/Pnas.1523265113  0.265
2020 Liang T, Qian ZM, Mu MD, Yung WH, Ke Y. Brain Hepcidin Suppresses Major Pathologies in Experimental Parkinsonism. Iscience. 23: 101284. PMID 32623334 DOI: 10.1016/J.Isci.2020.101284  0.26
1996 Chan E, Yung WH, Baumann KI. Cytoplasmic Ca2+ concentrations in intact Merkel cells of an isolated, functioning rat sinus hair preparation Experimental Brain Research. 108: 357-366. PMID 8801116 DOI: 10.1007/Bf00227259  0.259
2023 Lai SK, Wu KL, Ma CW, Ng KP, Hu XQ, Tam KW, Yung WH, Wang YT, Wong TP, Shum DK, Chan YS. Timely insertion of AMPA receptor in developing vestibular circuits is required for manifestation of righting reflexes and effective navigation. Progress in Neurobiology. 102402. PMID 36608782 DOI: 10.1016/j.pneurobio.2023.102402  0.257
2014 Du F, Qian ZM, Luo Q, Yung WH, Ke Y. Hepcidin Suppresses Brain Iron Accumulation by Downregulating Iron Transport Proteins in Iron-Overloaded Rats. Molecular Neurobiology. PMID 25115800 DOI: 10.1007/S12035-014-8847-X  0.255
2010 Zhao W, Wu X, Xie H, Ke Y, Yung WH. Permissive role of insulin in the expression of long-term potentiation in the hippocampus of immature rats. Neuro-Signals. 18: 236-45. PMID 21346324 DOI: 10.1159/000324040  0.255
2011 Qian ZM, Wu XM, Fan M, Yang L, Du F, Yung WH, Ke Y. Divalent metal transporter 1 is a hypoxia-inducible gene. Journal of Cellular Physiology. 226: 1596-603. PMID 20945371 DOI: 10.1002/Jcp.22485  0.252
2022 Qiao J, Yang S, Geng H, Yung WH, Ke Y. Input-timing-dependent plasticity at incoming synapses of the mushroom body facilitates olfactory learning in Drosophila. Current Biology : Cb. PMID 36265490 DOI: 10.1016/j.cub.2022.09.054  0.252
2001 Lee KM, Ye GL, Yung WH, Leung KS, Leung PC. In situ model for studying potassium currents in various growth plate chondrocyte subpopulations. Life Sciences. 69: 721-8. PMID 11476193 DOI: 10.1016/S0024-3205(01)01163-8  0.249
2020 Mu MD, Geng HY, Rong KL, Peng RC, Wang ST, Geng LT, Qian ZM, Yung WH, Ke Y. A limbic circuitry involved in emotional stress-induced grooming. Nature Communications. 11: 2261. PMID 32385304 DOI: 10.1038/S41467-020-16203-X  0.248
2015 Gong J, Du F, Qian ZM, Luo QQ, Sheng Y, Yung WH, Xu YX, Ke Y. Pre-treatment of rats with ad-hepcidin prevents iron-induced oxidative stress in the brain. Free Radical Biology & Medicine. PMID 26582371 DOI: 10.1016/J.Freeradbiomed.2015.11.016  0.245
2010 Du F, Zhu L, Qian ZM, Wu XM, Yung WH, Ke Y. Hyperthermic preconditioning protects astrocytes from ischemia/reperfusion injury by up-regulation of HIF-1 alpha expression and binding activity. Biochimica Et Biophysica Acta. 1802: 1048-53. PMID 20599612 DOI: 10.1016/J.Bbadis.2010.06.013  0.242
1990 Hausser MA, Yung WH. Bursting and non-bursting neurones in the guinea-pig substantia nigra pars compacta in vitro Journal of Physiology. 420: 27P.  0.234
2016 Lau OC, Shen B, Wong CO, Tjong YW, Lo CY, Wang HC, Huang Y, Yung WH, Chen YC, Fung ML, Rudd JA, Yao X. TRPC5 channels participate in pressure-sensing in aortic baroreceptors. Nature Communications. 7: 11947. PMID 27411851 DOI: 10.1038/Ncomms11947  0.232
2012 Leung TC, Lui CN, Chen LW, Yung WH, Chan YS, Yung KK. Ceftriaxone ameliorates motor deficits and protects dopaminergic neurons in 6-hydroxydopamine-lesioned rats. Acs Chemical Neuroscience. 3: 22-30. PMID 22860178 DOI: 10.1021/cn200072h  0.231
2012 Liu S, Li ZW, Weinreb RN, Xu G, Lindsey JD, Ye C, Yung WH, Pang CP, Lam DS, Leung CK. Tracking retinal microgliosis in models of retinal ganglion cell damage. Investigative Ophthalmology & Visual Science. 53: 6254-62. PMID 22879415 DOI: 10.1167/Iovs.12-9450  0.23
2016 Zhu ZJ, Wu KC, Yung WH, Qian ZM, Ke Y. Differential interaction between iron and mutant alpha-synuclein causes distinctive parkinsonian phenotypes in drosophila. Biochimica Et Biophysica Acta. PMID 26769358 DOI: 10.1016/J.Bbadis.2016.01.002  0.23
2017 Zhou YF, Wu XM, Zhou G, Mu MD, Zhang FL, Li FM, Qian C, Du F, Yung WH, Qian ZM, Ke Y. Cystathionine β-synthase is required for body iron homeostasis. Hepatology (Baltimore, Md.). PMID 28859237 DOI: 10.1002/Hep.29499  0.229
2021 Geng HY, Arbuthnott G, Yung WH, Ke Y. Long-Range Monosynaptic Inputs Targeting Apical and Basal Dendrites of Primary Motor Cortex Deep Output Neurons. Cerebral Cortex (New York, N.Y. : 1991). PMID 34905771 DOI: 10.1093/cercor/bhab460  0.228
2021 Wang Y, Fu WY, Cheung K, Hung KW, Chen C, Geng H, Yung WH, Qu JY, Fu AKY, Ip NY. Astrocyte-secreted IL-33 mediates homeostatic synaptic plasticity in the adult hippocampus. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 33443211 DOI: 10.1073/pnas.2020810118  0.227
2005 Leung CK, Chong KK, Chan WM, Yiu CK, Tso MY, Woo J, Tsang MK, Tse KK, Yung WH. Comparative study of retinal nerve fiber layer measurement by StratusOCT and GDx VCC, II: structure/function regression analysis in glaucoma. Investigative Ophthalmology & Visual Science. 46: 3702-11. PMID 16186352 DOI: 10.1167/iovs.05-0490  0.219
2022 Yu Y, Li JJ, He XQ, Lai ZY, Hao R, Qi Y, Cao DQ, Fu M, Ma H, Xie QC, Sun M, Huang ZL, Jin LJ, Sun HH, Lu N, ... ... Yung WH, et al. 5-HT3Rs Maintain Hippocampal LTP in a CB1R-GABA -Dependent Manner for Spatial Memory. British Journal of Pharmacology. PMID 34997582 DOI: 10.1111/bph.15793  0.217
2020 Shi Z, Xu L, Xie H, Ouyang R, Ke Y, Zhou R, Yung WH. Attenuation of intermittent hypoxia-induced apoptosis and fibrosis in pulmonary tissues via suppression of ER stress activation. Bmc Pulmonary Medicine. 20: 92. PMID 32299413 DOI: 10.1186/S12890-020-1123-0  0.213
2005 Leung CK, Chan WM, Hui YL, Yung WH, Woo J, Tsang MK, Tse KK. Analysis of retinal nerve fiber layer and optic nerve head in glaucoma with different reference plane offsets, using optical coherence tomography. Investigative Ophthalmology & Visual Science. 46: 891-9. PMID 15728545 DOI: 10.1167/iovs.04-1107  0.21
2005 Leung CK, Chan WM, Chong KK, Yung WH, Tang KT, Woo J, Chan WM, Tse KK. Comparative study of retinal nerve fiber layer measurement by StratusOCT and GDx VCC, I: correlation analysis in glaucoma. Investigative Ophthalmology & Visual Science. 46: 3214-20. PMID 16123421 DOI: 10.1167/iovs.05-0294  0.204
2016 Yang G, Hu R, Zhang C, Qian C, Luo QQ, Yung WH, Ke Y, Feng H, Qian ZM. A combination of serum iron, ferritin and transferrin predicts outcome in patients with intracerebral hemorrhage. Scientific Reports. 6: 21970. PMID 26898550 DOI: 10.1038/Srep21970  0.202
2015 Kim SJ, Lee HJ, Kim SW, Choi HJ, He J, Wu Q, Aldape KD, Weinberg JS, Yung WK, Conrad CA, Langley RR, Lehembre F, Regenass U, Fidler IJ. Macitentan, a dual endothelin receptor antagonist, in combination with temozolomide leads to glioblastoma regression and long-term survival in mice. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26106074 DOI: 10.1158/1078-0432.Ccr-14-3195  0.201
2018 Lau OC, Shen B, Wong CO, Tjong YW, Lo CY, Wang HC, Huang Y, Yung WH, Chen YC, Fung ML, Rudd JA, Yao X. Author Correction: TRPC5 channels participate in pressure-sensing in aortic baroreceptors. Nature Communications. 9: 16184. PMID 29569578 DOI: 10.1038/Ncomms16184  0.199
2005 Leung CK, Chan WM, Yung WH, Ng AC, Woo J, Tsang MK, Tse RK. Comparison of macular and peripapillary measurements for the detection of glaucoma: an optical coherence tomography study. Ophthalmology. 112: 391-400. PMID 15745764 DOI: 10.1016/j.ophtha.2004.10.020  0.194
2014 Tsang KH, Lai SK, Li Q, Yung WH, Liu H, Mak PH, Ng CC, McAlonan G, Chan YS, Chan SY. The nucleosome assembly protein TSPYL2 regulates the expression of NMDA receptor subunits GluN2A and GluN2B. Scientific Reports. 4: 3654. PMID 24413569 DOI: 10.1038/Srep03654  0.193
2007 Leung CK, Chan WM, Chong KK, Chan KC, Yung WH, Tsang MK, Tse RK, Lam DS. Alignment artifacts in optical coherence tomography analyzed images. Ophthalmology. 114: 263-70. PMID 17123619 DOI: 10.1016/j.ophtha.2006.06.059  0.191
2006 Leung CK, Yung WH, Yiu CK, Lam SW, Leung DY, Tse RK, Tham CC, Chan WM, Lam DS. Novel approach for anterior chamber angle analysis: anterior chamber angle detection with edge measurement and identification algorithm (ACADEMIA). Archives of Ophthalmology (Chicago, Ill. : 1960). 124: 1395-401. PMID 17030706 DOI: 10.1001/archopht.124.10.1395  0.189
2023 Liang T, Yang SX, Qian C, Du LD, Qian ZM, Yung WH, Ke Y. HMGB1 Mediates Inflammation-Induced DMT1 Increase and Dopaminergic Neurodegeneration in the Early Stage of Parkinsonism. Molecular Neurobiology. PMID 37833459 DOI: 10.1007/s12035-023-03668-2  0.185
2008 de Groot JF, Piao Y, Lu L, Fuller GN, Yung WK. Knockdown of GluR1 expression by RNA interference inhibits glioma proliferation. Journal of Neuro-Oncology. 88: 121-33. PMID 18317690 DOI: 10.1007/s11060-008-9552-2  0.181
2014 Li S, He Q, Wang H, Tang X, Ho KW, Gao X, Zhang Q, Shen Y, Cheung A, Wong F, Wong YH, Ip NY, Jiang L, Yung WH, Liu K. Injured adult retinal axons with Pten and Socs3 co-deletion reform active synapses with suprachiasmatic neurons. Neurobiology of Disease. 73: 366-376. PMID 25448764 DOI: 10.1016/J.Nbd.2014.09.019  0.163
2008 Wang Q, Du F, Qian ZM, Ge XH, Zhu L, Yung WH, Yang L, Ke Y. Lipopolysaccharide induces a significant increase in expression of iron regulatory hormone hepcidin in the cortex and substantia nigra in rat brain. Endocrinology. 149: 3920-5. PMID 18450970 DOI: 10.1210/En.2007-1626  0.157
2001 Mohanam S, Jasti SL, Kondraganti SR, Chandrasekar N, Kin Y, Fuller GN, Lakka SS, Kyritsis AP, Dinh DH, Olivero WC, Gujrati M, Yung WK, Rao JS. Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 7: 2519-26. PMID 11489835  0.15
2007 Koul D, Shen R, Shishodia S, Takada Y, Bhat KP, Reddy SA, Aggarwal BB, Yung WK. PTEN down regulates AP-1 and targets c-fos in human glioma cells via PI3-kinase/Akt pathway. Molecular and Cellular Biochemistry. 300: 77-87. PMID 17235455 DOI: 10.1007/s11010-006-9371-8  0.145
2006 Gomez-Manzano C, Alonso MM, Yung WK, McCormick F, Curiel DT, Lang FF, Jiang H, Bekele BN, Zhou X, Alemany R, Fueyo J. Delta-24 increases the expression and activity of topoisomerase I and enhances the antiglioma effect of irinotecan. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 556-62. PMID 16428500 DOI: 10.1158/1078-0432.Ccr-05-1892  0.144
2017 Lui NC, Tam WY, Gao C, Huang JD, Wang CC, Jiang L, Yung WH, Kwan KM. Lhx1/5 control dendritogenesis and spine morphogenesis of Purkinje cells via regulation of Espin. Nature Communications. 8: 15079. PMID 28516904 DOI: 10.1038/Ncomms15079  0.14
2005 de Groot JF, Liu TJ, Fuller G, Yung WK. The excitatory amino acid transporter-2 induces apoptosis and decreases glioma growth in vitro and in vivo. Cancer Research. 65: 1934-40. PMID 15753393 DOI: 10.1158/0008-5472.CAN-04-3626  0.139
2011 Leung CK, Weinreb RN, Li ZW, Liu S, Lindsey JD, Choi N, Liu L, Cheung CY, Ye C, Qiu K, Chen LJ, Yung WH, Crowston JG, Pu M, So KF, et al. Long-term in vivo imaging and measurement of dendritic shrinkage of retinal ganglion cells. Investigative Ophthalmology & Visual Science. 52: 1539-47. PMID 21245394 DOI: 10.1167/Iovs.10-6012  0.138
2022 Kumar G, Asthana P, Yung WH, Kwan KM, Tin C, Ma CHE. Deep Brain Stimulation of the Interposed Nucleus Reverses Motor Deficits and Stimulates Production of Anti-inflammatory Cytokines in Ataxia Mice. Molecular Neurobiology. PMID 35581519 DOI: 10.1007/s12035-022-02872-w  0.138
2020 Mu MD, Qian ZM, Yang SX, Rong KL, Yung WH, Ke Y. Therapeutic effect of a histone demethylase inhibitor in Parkinson's disease. Cell Death & Disease. 11: 927. PMID 33116116 DOI: 10.1038/s41419-020-03105-5  0.136
2014 Saito N, Fu J, Zheng S, Yao J, Wang S, Liu DD, Yuan Y, Sulman EP, Lang FF, Colman H, Verhaak RG, Yung WK, Koul D. A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor-initiating cells. Stem Cells (Dayton, Ohio). 32: 301-12. PMID 24038660 DOI: 10.1002/Stem.1528  0.132
2005 Alonso MM, Fueyo J, Shay JW, Aldape KD, Jiang H, Lee OH, Johnson DG, Xu J, Kondo Y, Kanzawa T, Kyo S, Bekele BN, Zhou X, Nigro J, McDonald JM, ... Yung WK, et al. Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance. Journal of the National Cancer Institute. 97: 1589-600. PMID 16264179 DOI: 10.1093/Jnci/Dji340  0.126
2006 Alonso MM, Fueyo J, Yung WK, Gomez-Manzano C. E2F1 and telomerase: alliance in the dark side. Cell Cycle (Georgetown, Tex.). 5: 930-5. PMID 16628012  0.125
2020 Li C, Yang X, Ke Y, Yung WH. Fully affine invariant methods for cross-session registration of calcium imaging data. Eneuro. PMID 32709595 DOI: 10.1523/ENEURO.0054-20.2020  0.125
2007 Liu JL, Mao Z, LaFortune TA, Alonso MM, Gallick GE, Fueyo J, Yung WK. Cell cycle-dependent nuclear export of phosphatase and tensin homologue tumor suppressor is regulated by the phosphoinositide-3-kinase signaling cascade. Cancer Research. 67: 11054-63. PMID 18006852 DOI: 10.1158/0008-5472.CAN-07-1263  0.124
2007 Jiang R, Choi W, Khan A, Hess K, Gerner EW, Casero RA, Yung WK, Hamilton SR, Zhang W. Activation of polyamine catabolism by N1,N11-diethylnorspermine leads to cell death in glioblastoma. International Journal of Oncology. 31: 431-40. PMID 17611701  0.124
2011 Liu JL, Mao Z, Gallick GE, Yung WK. AMPK/TSC2/mTOR-signaling intermediates are not necessary for LKB1-mediated nuclear retention of PTEN tumor suppressor. Neuro-Oncology. 13: 184-94. PMID 21123367 DOI: 10.1093/neuonc/noq163  0.123
2020 Peng RC, Liu XX, Ke Y, Yung WH. Randomized cortical stimulation could ameliorate locomotive inability in Parkinsonian rats: a pilot study. Biomedical Physics & Engineering Express. 6: 027002. PMID 33438644 DOI: 10.1088/2057-1976/Ab756E  0.122
2012 Koul D, Fu J, Shen R, LaFortune TA, Wang S, Tiao N, Kim YW, Liu JL, Ramnarian D, Yuan Y, Garcia-Echevrria C, Maira SM, Yung WK. Antitumor activity of NVP-BKM120--a selective pan class I PI3 kinase inhibitor showed differential forms of cell death based on p53 status of glioma cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 184-95. PMID 22065080 DOI: 10.1158/1078-0432.Ccr-11-1558  0.121
2001 Gomez-Manzano C, Mitlianga P, Fueyo J, Lee HY, Hu M, Spurgers KB, Glass TL, Koul D, Liu TJ, McDonnell TJ, Yung WK. Transfer of E2F-1 to human glioma cells results in transcriptional up-regulation of Bcl-2. Cancer Research. 61: 6693-7. PMID 11559537  0.121
2003 Fueyo J, Alemany R, Gomez-Manzano C, Fuller GN, Khan A, Conrad CA, Liu TJ, Jiang H, Lemoine MG, Suzuki K, Sawaya R, Curiel DT, Yung WK, Lang FF. Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway. Journal of the National Cancer Institute. 95: 652-60. PMID 12734316 DOI: 10.1093/Jnci/95.9.652  0.12
2005 Jiang H, Alemany R, Gomez-Manzano C, Medrano DR, Lemoine MG, Olson MV, Alonso MM, Lee OH, Conrad CC, Yung WK, Fueyo J. Downmodulation of E1A protein expression as a novel strategy to design cancer-selective adenoviruses. Neoplasia (New York, N.Y.). 7: 723-9. PMID 16207474  0.119
2011 Guan S, Shen R, Lafortune T, Tiao N, Houghton P, Yung WK, Koul D. Establishment and characterization of clinically relevant models of ependymoma: a true challenge for targeted therapy. Neuro-Oncology. 13: 748-58. PMID 21653596 DOI: 10.1093/neuonc/nor037  0.119
1985 Yung WH, Chiu KW. Contractile response of the isolated dorsal aorta of the snake to angiotensin II and norepinephrine General and Comparative Endocrinology. 60: 259-265. PMID 4065534 DOI: 10.1016/0016-6480(85)90322-3  0.119
2007 Liu TJ, LaFortune T, Honda T, Ohmori O, Hatakeyama S, Meyer T, Jackson D, de Groot J, Yung WK. Inhibition of both focal adhesion kinase and insulin-like growth factor-I receptor kinase suppresses glioma proliferation in vitro and in vivo. Molecular Cancer Therapeutics. 6: 1357-67. PMID 17431114 DOI: 10.1158/1535-7163.MCT-06-0476  0.118
2006 Koul D, Shen R, Bergh S, Sheng X, Shishodia S, Lafortune TA, Lu Y, de Groot JF, Mills GB, Yung WK. Inhibition of Akt survival pathway by a small-molecule inhibitor in human glioblastoma. Molecular Cancer Therapeutics. 5: 637-44. PMID 16546978 DOI: 10.1158/1535-7163.MCT-05-0453  0.118
2005 Zhou YH, Wu X, Tan F, Shi YX, Glass T, Liu TJ, Wathen K, Hess KR, Gumin J, Lang F, Yung WK. PAX6 suppresses growth of human glioblastoma cells. Journal of Neuro-Oncology. 71: 223-9. PMID 15735909 DOI: 10.1007/s11060-004-1720-4  0.116
2006 Koul D, Takada Y, Shen R, Aggarwal BB, Yung WK. PTEN enhances TNF-induced apoptosis through modulation of nuclear factor-kappaB signaling pathway in human glioma cells. Biochemical and Biophysical Research Communications. 350: 463-71. PMID 17011514 DOI: 10.1016/j.bbrc.2006.09.077  0.115
2001 Lakka SS, Rajagopal R, Rajan MK, Mohan PM, Adachi Y, Dinh DH, Olivero WC, Gujrati M, Ali-Osman F, Roth JA, Yung WK, Kyritsis AP, Rao JS. Adenovirus-mediated antisense urokinase-type plasminogen activator receptor gene transfer reduces tumor cell invasion and metastasis in non-small cell lung cancer cell lines. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 7: 1087-93. PMID 11309361  0.115
2009 Liu TJ, Koul D, LaFortune T, Tiao N, Shen RJ, Maira SM, Garcia-Echevrria C, Yung WK. NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas. Molecular Cancer Therapeutics. 8: 2204-10. PMID 19671762 DOI: 10.1158/1535-7163.Mct-09-0160  0.115
2000 Hong YK, Joe YA, Yang YJ, Lee KS, Son BC, Jeun SS, Chung DS, Cho KK, Park CK, Kim MC, Kim HK, Yung WK, Kang JK. Potentials and limitations of adenovirus-p53 gene therapy for brain tumors. Journal of Korean Medical Science. 15: 315-22. PMID 10895975  0.115
2011 Atkinson JM, Shelat AA, Carcaboso AM, Kranenburg TA, Arnold LA, Boulos N, Wright K, Johnson RA, Poppleton H, Mohankumar KM, Féau C, Phoenix T, Gibson P, Zhu L, Tong Y, ... ... Yung WK, et al. An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymoma. Cancer Cell. 20: 384-99. PMID 21907928 DOI: 10.1016/J.Ccr.2011.08.013  0.113
2007 Xia D, Srinivas H, Ahn YH, Sethi G, Sheng X, Yung WK, Xia Q, Chiao PJ, Kim H, Brown PH, Wistuba II, Aggarwal BB, Kurie JM. Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expression through an NF kappa B-dependent pathway. The Journal of Biological Chemistry. 282: 3507-19. PMID 17158870 DOI: 10.1074/Jbc.M610141200  0.113
2000 Glass TL, Liu TJ, Yung WK. Inhibition of cell growth in human glioblastoma cell lines by farnesyltransferase inhibitor SCH66336. Neuro-Oncology. 2: 151-8. PMID 11302335  0.112
2008 He W, Qian Zhong M, Zhu L, Christopher Q, Du F, Yung WH, Ke Y. Ginkgolides mimic the effects of hypoxic preconditioning to protect C6 cells against ischemic injury by up-regulation of hypoxia-inducible factor-1 alpha and erythropoietin. The International Journal of Biochemistry & Cell Biology. 40: 651-62. PMID 18054269 DOI: 10.1016/J.Biocel.2007.10.013  0.112
2006 Jiang H, Olson MV, Medrano DR, Lee OH, Xu J, Piao Y, Alonso MM, Gomez-Manzano C, Hung MC, Yung WK, Fueyo J. A novel CRM1-dependent nuclear export signal in adenoviral E1A protein regulated by phosphorylation. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 2603-5. PMID 17065226 DOI: 10.1096/fj.06-6433fje  0.11
2001 Fueyo J, Gomez-Manzano C, Liu TJ, Yung WK. Delivery of cell cycle genes to block astrocytoma growth. Journal of Neuro-Oncology. 51: 277-87. PMID 11407598  0.109
2005 Conrad C, Miller CR, Ji Y, Gomez-Manzano C, Bharara S, McMurray JS, Lang FF, Wong F, Sawaya R, Yung WK, Fueyo J. Delta24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitization. Cancer Gene Therapy. 12: 284-94. PMID 15650766 DOI: 10.1038/Sj.Cgt.7700750  0.109
2004 Gomez-Manzano C, Balague C, Alemany R, Lemoine MG, Mitlianga P, Jiang H, Khan A, Alonso M, Lang FF, Conrad CA, Liu TJ, Bekele BN, Yung WK, Fueyo J. A novel E1A-E1B mutant adenovirus induces glioma regression in vivo. Oncogene. 23: 1821-8. PMID 15014451 DOI: 10.1038/Sj.Onc.1207321  0.109
2001 Koul D, Yao Y, Abbruzzese JL, Yung WK, Reddy SA. Tumor suppressor MMAC/PTEN inhibits cytokine-induced NFkappaB activation without interfering with the IkappaB degradation pathway. The Journal of Biological Chemistry. 276: 11402-8. PMID 11278366 DOI: 10.1074/jbc.M007806200  0.107
2005 Koul D, Shen R, Bergh S, Lu Y, de Groot JF, Liu TJ, Mills GB, Yung WK. Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma. Molecular Cancer Therapeutics. 4: 1681-8. PMID 16275989 DOI: 10.1158/1535-7163.MCT-05-0258  0.107
2001 Mitlianga PG, Kyritsis AP, Gomez-Manzano C, Lemoine MG, Hu M, Liu TJ, Yung WK, Fueyo J. Co-expression of E2F-2 enhances the p53 anti-cancer effect in human glioma cells. International Journal of Oncology. 18: 343-7. PMID 11172602 DOI: 10.3892/Ijo.18.2.343  0.105
2013 Fu J, Koul D, Yao J, Wang S, Yuan Y, Colman H, Sulman EP, Lang FF, Yung WK. Novel HSP90 inhibitor NVP-HSP990 targets cell-cycle regulators to ablate Olig2-positive glioma tumor-initiating cells. Cancer Research. 73: 3062-74. PMID 23492364 DOI: 10.1158/0008-5472.Can-12-2033  0.105
2010 Koul D, Shen R, Kim YW, Kondo Y, Lu Y, Bankson J, Ronen SM, Kirkpatrick DL, Powis G, Yung WK. Cellular and in vivo activity of a novel PI3K inhibitor, PX-866, against human glioblastoma. Neuro-Oncology. 12: 559-69. PMID 20156803 DOI: 10.1093/Neuonc/Nop058  0.104
2000 Lakka SS, Jasti SL, Kyritsis AP, Yung WK, Ali-Osman F, Nicolson GL, Rao JS. Regulation of MMP-9 (type IV collagenase) production and invasiveness in gliomas by the extracellular signal-regulated kinase and jun amino-terminal kinase signaling cascades. Clinical & Experimental Metastasis. 18: 245-52. PMID 11315098 DOI: 10.1023/A:1006724826083  0.103
2005 Lassman AB, Rossi MR, Raizer JJ, Razier JR, Abrey LE, Lieberman FS, Grefe CN, Lamborn K, Pao W, Shih AH, Kuhn JG, Wilson R, Nowak NJ, Cowell JK, DeAngelis LM, ... ... Yung WA, et al. Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 7841-50. PMID 16278407 DOI: 10.1158/1078-0432.Ccr-05-0421  0.103
2004 Gomez-Manzano C, Yung WK, Alemany R, Fueyo J. Genetically modified adenoviruses against gliomas: from bench to bedside. Neurology. 63: 418-26. PMID 15304571  0.102
2005 Unni E, Koul D, Yung WK, Sinha R. Se-methylselenocysteine inhibits phosphatidylinositol 3-kinase activity of mouse mammary epithelial tumor cells in vitro. Breast Cancer Research : Bcr. 7: R699-707. PMID 16168115 DOI: 10.1186/bcr1276  0.101
2007 Xia Y, Wang J, Liu TJ, Yung WK, Hunter T, Lu Z. c-Jun downregulation by HDAC3-dependent transcriptional repression promotes osmotic stress-induced cell apoptosis. Molecular Cell. 25: 219-32. PMID 17244530 DOI: 10.1016/J.Molcel.2007.01.005  0.099
2003 Gomez-Manzano C, Fueyo J, Jiang H, Glass TL, Lee HY, Hu M, Liu JL, Jasti SL, Liu TJ, Conrad CA, Yung WK. Mechanisms underlying PTEN regulation of vascular endothelial growth factor and angiogenesis. Annals of Neurology. 53: 109-17. PMID 12509854 DOI: 10.1002/ana.10396  0.098
2012 Reardon DA, Conrad CA, Cloughesy T, Prados MD, Friedman HS, Aldape KD, Mischel P, Xia J, DiLea C, Huang J, Mietlowski W, Dugan M, Chen W, Yung WK. Phase I study of AEE788, a novel multitarget inhibitor of ErbB- and VEGF-receptor-family tyrosine kinases, in recurrent glioblastoma patients. Cancer Chemotherapy and Pharmacology. 69: 1507-18. PMID 22392572 DOI: 10.1007/S00280-012-1854-6  0.095
2013 Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ, Berman SH, Beroukhim R, Bernard B, Wu CJ, Genovese G, Shmulevich I, ... ... Yung WK, et al. The somatic genomic landscape of glioblastoma. Cell. 155: 462-77. PMID 24120142 DOI: 10.1016/J.Cell.2013.09.034  0.094
2007 Olson MV, Johnson DG, Jiang H, Xu J, Alonso MM, Aldape KD, Fuller GN, Bekele BN, Yung WK, Gomez-Manzano C, Fueyo J. Transgenic E2F1 expression in the mouse brain induces a human-like bimodal pattern of tumors. Cancer Research. 67: 4005-9. PMID 17483310 DOI: 10.1158/0008-5472.Can-06-2973  0.094
2001 Koul D, Parthasarathy R, Shen R, Davies MA, Jasser SA, Chintala SK, Rao JS, Sun Y, Benvenisite EN, Liu TJ, Yung WK. Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN. Oncogene. 20: 6669-78. PMID 11709701 DOI: 10.1038/sj.onc.1204799  0.094
2007 Pelloski CE, Ballman KV, Furth AF, Zhang L, Lin E, Sulman EP, Bhat K, McDonald JM, Yung WK, Colman H, Woo SY, Heimberger AB, Suki D, Prados MD, Chang SM, et al. Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 2288-94. PMID 17538175 DOI: 10.1200/JCO.2006.08.0705  0.094
2006 Mayes DA, Hu Y, Teng Y, Siegel E, Wu X, Panda K, Tan F, Yung WK, Zhou YH. PAX6 suppresses the invasiveness of glioblastoma cells and the expression of the matrix metalloproteinase-2 gene. Cancer Research. 66: 9809-17. PMID 17047041 DOI: 10.1158/0008-5472.Can-05-3877  0.094
2005 Zhou YH, Hess KR, Liu L, Linskey ME, Yung WK. Modeling prognosis for patients with malignant astrocytic gliomas: quantifying the expression of multiple genetic markers and clinical variables. Neuro-Oncology. 7: 485-94. PMID 16212813 DOI: 10.1215/S1152851704000730  0.093
2007 Alonso MM, Gomez-Manzano C, Bekele BN, Yung WK, Fueyo J. Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoter. Cancer Research. 67: 11499-504. PMID 18089777 DOI: 10.1158/0008-5472.CAN-07-5312  0.093
2013 Zhao Q, Caballero OL, Davis ID, Jonasch E, Tamboli P, Yung WK, Weinstein JN, Strausberg RL, Yao J. Tumor-specific isoform switch of the fibroblast growth factor receptor 2 underlies the mesenchymal and malignant phenotypes of clear cell renal cell carcinomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 2460-72. PMID 23444225 DOI: 10.1158/1078-0432.CCR-12-3708  0.093
2024 Liang T, Peng RC, Rong KL, Li JX, Ke Y, Yung WH. Disparate processing of numerosity and associated continuous magnitudes in rats. Science Advances. 10: eadj2566. PMID 38381814 DOI: 10.1126/sciadv.adj2566  0.092
2003 Zhou YH, Tan F, Hess KR, Yung WK. The expression of PAX6, PTEN, vascular endothelial growth factor, and epidermal growth factor receptor in gliomas: relationship to tumor grade and survival. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 3369-75. PMID 12960124  0.089
2002 Sheng X, Koul D, Liu JL, Liu TJ, Yung WK. Promoter analysis of tumor suppressor gene PTEN: identification of minimum promoter region. Biochemical and Biophysical Research Communications. 292: 422-6. PMID 11906179 DOI: 10.1006/bbrc.2002.6662  0.089
2003 Lu Y, Yu Q, Liu JH, Zhang J, Wang H, Koul D, McMurray JS, Fang X, Yung WK, Siminovitch KA, Mills GB. Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades. The Journal of Biological Chemistry. 278: 40057-66. PMID 12869565 DOI: 10.1074/jbc.M303621200  0.088
2006 Kook H, Yung WW, Simpson RJ, Kee HJ, Shin S, Lowry JA, Loughlin FE, Yin Z, Epstein JA, Mackay JP. Analysis of the structure and function of the transcriptional coregulator HOP. Biochemistry. 45: 10584-90. PMID 16939210 DOI: 10.1021/Bi060641S  0.088
2009 Wen PY, Yung WK, Lamborn KR, Norden AD, Cloughesy TF, Abrey LE, Fine HA, Chang SM, Robins HI, Fink K, Deangelis LM, Mehta M, Di Tomaso E, Drappatz J, Kesari S, et al. Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08). Neuro-Oncology. 11: 853-60. PMID 19293394 DOI: 10.1215/15228517-2009-010  0.087
2004 Cerrato JA, Khan T, Koul D, Lang FF, Conrad CA, Yung WK, Liu TJ. Differential activation of the Fas/CD95 pathway by Ad-p53 in human gliomas. International Journal of Oncology. 24: 409-17. PMID 14719118 DOI: 10.3892/Ijo.24.2.409  0.087
2006 Liew CW, Rand KD, Simpson RJ, Yung WW, Mansfield RE, Crossley M, Proetorius-Ibba M, Nerlov C, Poulsen FM, Mackay JP. Molecular analysis of the interaction between the hematopoietic master transcription factors GATA-1 and PU.1. The Journal of Biological Chemistry. 281: 28296-306. PMID 16861236 DOI: 10.1074/Jbc.M602830200  0.087
2011 Kim YW, Liu TJ, Koul D, Tiao N, Feroze AH, Wang J, Powis G, Yung WK. Identification of novel synergistic targets for rational drug combinations with PI3 kinase inhibitors using siRNA synthetic lethality screening against GBM. Neuro-Oncology. 13: 367-75. PMID 21430111 DOI: 10.1093/neuonc/nor012  0.086
2015 Jiang J, Zhang D, Walker S, Gu C, Ke Y, Yung WH, Chen SC. Fast 3-D temporal focusing microscopy using an electrically tunable lens. Optics Express. 23: 24362-8. PMID 26406641 DOI: 10.1364/Oe.23.024362  0.085
2022 Lam YS, Li J, Ke Y, Yung WH. Variational dimensions of cingulate cortex functional connectivity and implications in neuropsychiatric disorders. Cerebral Cortex (New York, N.Y. : 1991). PMID 35193144 DOI: 10.1093/cercor/bhac045  0.084
2005 Liu JL, Sheng X, Hortobagyi ZK, Mao Z, Gallick GE, Yung WK. Nuclear PTEN-mediated growth suppression is independent of Akt down-regulation. Molecular and Cellular Biology. 25: 6211-24. PMID 15988030 DOI: 10.1128/MCB.25.14.6211-6224.2005  0.083
2001 Cerrato JA, Yung WK, Liu TJ. Introduction of mutant p53 into a wild-type p53-expressing glioma cell line confers sensitivity to Ad-p53-induced apoptosis. Neuro-Oncology. 3: 113-22. PMID 11296482 DOI: 10.1093/Neuonc/3.2.113  0.083
2011 Zhang N, Wei P, Gong A, Chiu WT, Lee HT, Colman H, Huang H, Xue J, Liu M, Wang Y, Sawaya R, Xie K, Yung WK, Medema RH, He X, et al. FoxM1 promotes β-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis. Cancer Cell. 20: 427-42. PMID 22014570 DOI: 10.1016/j.ccr.2011.08.016  0.082
2015 Turner KM, Sun Y, Ji P, Granberg KJ, Bernard B, Hu L, Cogdell DE, Zhou X, Yli-Harja O, Nykter M, Shmulevich I, Yung WK, Fuller GN, Zhang W. Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression. Proceedings of the National Academy of Sciences of the United States of America. 112: 3421-6. PMID 25737557 DOI: 10.1073/pnas.1414573112  0.081
2014 Desai S, Ding M, Wang B, Lu Z, Zhao Q, Shaw K, Yung WK, Weinstein JN, Tan M, Yao J. Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers. Oncotarget. 5: 8202-10. PMID 24077665 DOI: 10.18632/Oncotarget.1159  0.081
2023 Du L, He X, Fan X, Wei X, Xu L, Liang T, Wang C, Ke Y, Yung WH. Pharmacological interventions targeting α-synuclein aggregation triggered REM sleep behavior disorder and early development of Parkinson's disease. Pharmacology & Therapeutics. 108498. PMID 37499913 DOI: 10.1016/j.pharmthera.2023.108498  0.081
2013 Zheng S, Fu J, Vegesna R, Mao Y, Heathcock LE, Torres-Garcia W, Ezhilarasan R, Wang S, McKenna A, Chin L, Brennan CW, Yung WK, Weinstein JN, Aldape KD, Sulman EP, et al. A survey of intragenic breakpoints in glioblastoma identifies a distinct subset associated with poor survival. Genes & Development. 27: 1462-72. PMID 23796897 DOI: 10.1101/Gad.213686.113  0.08
2005 Nigro JM, Misra A, Zhang L, Smirnov I, Colman H, Griffin C, Ozburn N, Chen M, Pan E, Koul D, Yung WK, Feuerstein BG, Aldape KD. Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma. Cancer Research. 65: 1678-86. PMID 15753362 DOI: 10.1158/0008-5472.Can-04-2921  0.079
2002 Koul D, Jasser SA, Lu Y, Davies MA, Shen R, Shi Y, Mills GB, Yung WK. Motif analysis of the tumor suppressor gene MMAC/PTEN identifies tyrosines critical for tumor suppression and lipid phosphatase activity. Oncogene. 21: 2357-64. PMID 11948419 DOI: 10.1038/sj.onc.1205296  0.079
2009 Ge XH, Wang Q, Qian ZM, Zhu L, Du F, Yung WH, Yang L, Ke Y. The iron regulatory hormone hepcidin reduces ferroportin 1 content and iron release in H9C2 cardiomyocytes. The Journal of Nutritional Biochemistry. 20: 860-5. PMID 19027283 DOI: 10.1016/J.Jnutbio.2008.07.014  0.078
2008 Gomez-Manzano C, Holash J, Fueyo J, Xu J, Conrad CA, Aldape KD, de Groot JF, Bekele BN, Yung WK. VEGF Trap induces antiglioma effect at different stages of disease. Neuro-Oncology. 10: 940-5. PMID 18708344 DOI: 10.1215/15228517-2008-061  0.078
2008 de Groot JF, Yung WK. Bevacizumab and irinotecan in the treatment of recurrent malignant gliomas. Cancer Journal (Sudbury, Mass.). 14: 279-85. PMID 18836331 DOI: 10.1097/PPO.0b013e3181867bd6  0.078
2014 Zhu ZJ, Wu KC, Qian ZM, Yung WH, Ke Y. Drosophila models for studying iron-related neurodegenerative diseases. Sheng Li Xue Bao : [Acta Physiologica Sinica]. 66: 47-54. PMID 24553869  0.078
2011 de Groot JF, Piao Y, Tran H, Gilbert M, Wu HK, Liu J, Bekele BN, Cloughesy T, Mehta M, Robins HI, Lassman A, DeAngelis L, Camphausen K, Chen A, Yung WK, et al. Myeloid biomarkers associated with glioblastoma response to anti-VEGF therapy with aflibercept. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 4872-81. PMID 21632852 DOI: 10.1158/1078-0432.Ccr-11-0271  0.076
2012 Lee EQ, Kuhn J, Lamborn KR, Abrey L, DeAngelis LM, Lieberman F, Robins HI, Chang SM, Yung WK, Drappatz J, Mehta MP, Levin VA, Aldape K, Dancey JE, Wright JJ, et al. Phase I/II study of sorafenib in combination with temsirolimus for recurrent glioblastoma or gliosarcoma: North American Brain Tumor Consortium study 05-02. Neuro-Oncology. 14: 1511-8. PMID 23099651 DOI: 10.1093/Neuonc/Nos264  0.076
2002 Koul D, Shen R, Garyali A, Ke LD, Liu TJ, Yung WK. MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer. International Journal of Oncology. 21: 469-75. PMID 12168088 DOI: 10.3892/Ijo.21.3.469  0.076
2006 Lee OH, Fueyo J, Xu J, Yung WK, Lemoine MG, Lang FF, Bekele BN, Zhou X, Alonso MA, Aldape KD, Fuller GN, Gomez-Manzano C. Sustained angiopoietin-2 expression disrupts vessel formation and inhibits glioma growth. Neoplasia (New York, N.Y.). 8: 419-28. PMID 16790091 DOI: 10.1593/Neo.06109  0.074
2014 Wen PY, Chang SM, Lamborn KR, Kuhn JG, Norden AD, Cloughesy TF, Robins HI, Lieberman FS, Gilbert MR, Mehta MP, Drappatz J, Groves MD, Santagata S, Ligon AH, Yung WK, et al. Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02. Neuro-Oncology. 16: 567-78. PMID 24470557 DOI: 10.1093/Neuonc/Not247  0.074
2014 Jiang H, Clise-Dwyer K, Ruisaard KE, Fan X, Tian W, Gumin J, Lamfers ML, Kleijn A, Lang FF, Yung WK, Vence LM, Gomez-Manzano C, Fueyo J. Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse model. Plos One. 9: e97407. PMID 24827739 DOI: 10.1371/Journal.Pone.0097407  0.074
2007 Alonso MM, Gomez-Manzano C, Jiang H, Bekele NB, Piao Y, Yung WK, Alemany R, Fueyo J. Combination of the oncolytic adenovirus ICOVIR-5 with chemotherapy provides enhanced anti-glioma effect in vivo. Cancer Gene Therapy. 14: 756-61. PMID 17557108 DOI: 10.1038/sj.cgt.7701067  0.073
2022 Lam YS, Liu XX, Ke Y, Yung WH. Edge-based network analysis reveals frequency-specific network dynamics in aberrant anxiogenic processing in rats. Network Neuroscience (Cambridge, Mass.). 6: 816-833. PMID 36605411 DOI: 10.1162/netn_a_00251  0.073
2006 Pelloski CE, Lin E, Zhang L, Yung WK, Colman H, Liu JL, Woo SY, Heimberger AB, Suki D, Prados M, Chang S, Barker FG, Fuller GN, Aldape KD. Prognostic associations of activated mitogen-activated protein kinase and Akt pathways in glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 3935-41. PMID 16818690 DOI: 10.1158/1078-0432.Ccr-05-2202  0.073
2021 Li R, Li Y, Mu M, Yang B, Chen X, Lee WYW, Ke Y, Yung WH, Tang BZ, Bian L. Multifunctional Nanoprobe for the Delivery of Therapeutic siRNA and Real-Time Molecular Imaging of Parkinson's Disease Biomarkers. Acs Applied Materials & Interfaces. PMID 33683858 DOI: 10.1021/acsami.0c22112  0.072
2000 Ke LD, Shi YX, Im SA, Chen X, Yung WK. The relevance of cell proliferation, vascular endothelial growth factor, and basic fibroblast growth factor production to angiogenesis and tumorigenicity in human glioma cell lines. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 6: 2562-72. PMID 10873113  0.072
2001 Im SA, Kim JS, Gomez-Manzano C, Fueyo J, Liu TJ, Cho MS, Seong CM, Lee SN, Hong YK, Yung WK. Inhibition of breast cancer growth in vivo by antiangiogenesis gene therapy with adenovirus-mediated antisense-VEGF. British Journal of Cancer. 84: 1252-7. PMID 11336478 DOI: 10.1054/bjoc.2000.1734  0.072
2005 Jiang H, Gomez-Manzano C, Alemany R, Medrano D, Alonso M, Bekele BN, Lin E, Conrad CC, Yung WK, Fueyo J. Comparative effect of oncolytic adenoviruses with E1A-55 kDa or E1B-55 kDa deletions in malignant gliomas. Neoplasia (New York, N.Y.). 7: 48-56. PMID 15720816 DOI: 10.1593/neo.04391  0.071
2012 Pope WB, Qiao XJ, Kim HJ, Lai A, Nghiemphu P, Xue X, Ellingson BM, Schiff D, Aregawi D, Cha S, Puduvalli VK, Wu J, Yung WK, Young GS, Vredenburgh J, et al. Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study. Journal of Neuro-Oncology. 108: 491-8. PMID 22426926 DOI: 10.1007/s11060-012-0847-y  0.071
2007 Jou IM, Tai TW, Tsai CL, Tsai TM, Yung WS, Jung YC. Spinal somatosensory evoked potential to evaluate neurophysiologic changes associated with postlaminotomy fibrosis: an experimental study. Spine. 32: 2111-8. PMID 17762813 DOI: 10.1097/BRS.0b013e3181453fa5  0.07
2011 Fueyo J, Gomez-Manzano C, Yung WK. Advances in translational research in neuro-oncology. Archives of Neurology. 68: 303-8. PMID 21059986 DOI: 10.1001/archneurol.2010.293  0.069
2018 Zhang MW, Zhao P, Yung WH, Sheng Y, Ke Y, Qian ZM. Tissue iron is negatively correlated with TERC or TERT mRNA expression: a heterochronic parabiosis study in mice. Aging. PMID 30555055 DOI: 10.18632/aging.101676  0.069
2010 Yung WK, Vredenburgh JJ, Cloughesy TF, Nghiemphu P, Klencke B, Gilbert MR, Reardon DA, Prados MD. Safety and efficacy of erlotinib in first-relapse glioblastoma: a phase II open-label study. Neuro-Oncology. 12: 1061-70. PMID 20615922 DOI: 10.1093/Neuonc/Noq072  0.069
2014 Yao J, Caballero OL, Yung WK, Weinstein JN, Riggins GJ, Strausberg RL, Zhao Q. Tumor subtype-specific cancer-testis antigens as potential biomarkers and immunotherapeutic targets for cancers. Cancer Immunology Research. 2: 371-9. PMID 24764584 DOI: 10.1158/2326-6066.CIR-13-0088  0.068
2000 Caskey LS, Fuller GN, Bruner JM, Yung WK, Sawaya RE, Holland EC, Zhang W. Toward a molecular classification of the gliomas: histopathology, molecular genetics, and gene expression profiling. Histology and Histopathology. 15: 971-81. PMID 10963139 DOI: 10.14670/Hh-15.971  0.068
2014 Peng Z, Maxwell D, Sun D, Ying Y, Schuber PT, Bhanu Prasad BA, Gelovani J, Yung WK, Bornmann WG. Design and Synthesis of an Inositol Phosphate Analog Based on Computational Docking Studies. Tetrahedron. 70: 984-990. PMID 25110363 DOI: 10.1016/J.Tet.2013.11.092  0.068
2002 Lang FF, Gilbert MR, Puduvalli VK, Weinberg J, Levin VA, Yung WK, Sawaya R, Fuller GN, Conrad CA. Toward better early-phase brain tumor clinical trials: a reappraisal of current methods and proposals for future strategies. Neuro-Oncology. 4: 268-77. PMID 12356357 DOI: 10.1093/Neuonc/4.4.268  0.068
2013 Kim YW, Koul D, Kim SH, Lucio-Eterovic AK, Freire PR, Yao J, Wang J, Almeida JS, Aldape K, Yung WK. Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis. Neuro-Oncology. 15: 829-39. PMID 23502430 DOI: 10.1093/Neuonc/Not024  0.067
2011 Wen PY, Schiff D, Cloughesy TF, Reardon DA, Batchelor TT, Chabner BA, Flaherty K, de Groot JF, Gilbert MR, Galanis E, Chang SM, Schwartz GK, Peereboom D, Mehta MP, Yung WK, et al. It is time to include patients with brain tumors in phase I trials in oncology. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 3211-3. PMID 21768451 DOI: 10.1200/Jco.2011.36.6328  0.066
2014 Guan X, Vengoechea J, Zheng S, Sloan AE, Chen Y, Brat DJ, O'Neill BP, de Groot J, Yust-Katz S, Yung WK, Cohen ML, Aldape KD, Rosenfeld S, Verhaak RG, Barnholtz-Sloan JS. Molecular subtypes of glioblastoma are relevant to lower grade glioma. Plos One. 9: e91216. PMID 24614622 DOI: 10.1371/Journal.Pone.0091216  0.065
2014 Koul D, Yao J, Wan S, Yuan Y, Sulman E, Lang F, Yung WK, Colman H. Retraction: Novel HSP90 inhibitor NVP-HSP990 targets cell-cycle regulators to ablate Olig 2-positive glioma tumor-initiating cells. Cancer Research. 74: 6731-2. PMID 25398854 DOI: 10.1158/0008-5472.Can-14-2966  0.065
2004 Prados MD, Yung WK, Fine HA, Greenberg HS, Junck L, Chang SM, Nicholas MK, Robins HI, Mehta MP, Fink KL, Jaeckle KA, Kuhn J, Hess KR, Schold SC. Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study. Neuro-Oncology. 6: 33-7. PMID 14769138 DOI: 10.1215/S1152851703000309  0.063
2003 Reardon DA, Friedman HS, Powell JB, Gilbert M, Yung WK. Irinotecan: promising activity in the treatment of malignant glioma. Oncology (Williston Park, N.Y.). 17: 9-14. PMID 12800600  0.063
2011 Du F, Qian ZM, Zhu L, Wu XM, Yung WH, Ke Y. A synergistic role of hyperthermic and pharmacological preconditioning to protect astrocytes against ischemia/reperfusion injury. Neurochemical Research. 36: 312-8. PMID 21127970 DOI: 10.1007/S11064-010-0327-8  0.063
2011 Prados M, Cloughesy T, Samant M, Fang L, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Das A, Friedman HS. Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab. Neuro-Oncology. 13: 143-51. PMID 21084434 DOI: 10.1093/Neuonc/Noq151  0.062
2008 de Groot JF, Gilbert MR, Aldape K, Hess KR, Hanna TA, Ictech S, Groves MD, Conrad C, Colman H, Puduvalli VK, Levin V, Yung WK. Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma. Journal of Neuro-Oncology. 90: 89-97. PMID 18581057 DOI: 10.1007/S11060-008-9637-Y  0.062
2000 Hong YK, Chung DS, Joe YA, Yang YJ, Kim KM, Park YS, Yung WK, Kang JK. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 6: 3354-60. PMID 10955823  0.062
2012 Yao J, Zhao Q, Yuan Y, Zhang L, Liu X, Yung WK, Weinstein JN. Identification of common prognostic gene expression signatures with biological meanings from microarray gene expression datasets. Plos One. 7: e45894. PMID 23029298 DOI: 10.1371/Journal.Pone.0045894  0.061
2003 Dabaja BS, McLaughlin P, Ha CS, Pro B, Meyers CA, Seabrooke LF, Wilder RB, Kyritsis AP, Preti HA, Yung WK, Levin V, Cabanillas F, Cox JD. Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy. Cancer. 98: 1021-8. PMID 12942571 DOI: 10.1002/cncr.11627  0.06
2013 Yust-Katz S, Liu D, Yuan Y, Liu V, Kang S, Groves M, Puduvalli V, Levin V, Conrad C, Colman H, Hsu S, Yung WK, Gilbert MR. Phase 1/1b study of lonafarnib and temozolomide in patients with recurrent or temozolomide refractory glioblastoma. Cancer. 119: 2747-53. PMID 23633392 DOI: 10.1002/Cncr.28031  0.06
2006 Levin VA, Giglio P, Puduvalli VK, Jochec J, Groves MD, Yung WK, Hess K. Combination chemotherapy with 13-cis-retinoic acid and celecoxib in the treatment of glioblastoma multiforme. Journal of Neuro-Oncology. 78: 85-90. PMID 16391896 DOI: 10.1007/S11060-005-9062-4  0.06
2010 Vredenburgh JJ, Cloughesy T, Samant M, Prados M, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Das A, Friedman HS. Corticosteroid use in patients with glioblastoma at first or second relapse treated with bevacizumab in the BRAIN study. The Oncologist. 15: 1329-34. PMID 21147867 DOI: 10.1634/Theoncologist.2010-0105  0.06
2000 Osoba D, Brada M, Yung WK, Prados MD. Health-related quality of life in patients with anaplastic astrocytoma during treatment with temozolomide. European Journal of Cancer (Oxford, England : 1990). 36: 1788-95. PMID 10974627 DOI: 10.1016/S0959-8049(00)00165-9  0.06
2012 Fung HT, Yung WH, Crow P, Lam KK, Ho KK, Tan KS, Lam SK, Ke Y, Grioni A, Wong OF, Ades G, Kam CW, Tse ML. Green pit viper antivenom from Thailand and Agkistrodon halys antivenom from China compared in treating Cryptelytrops albolabris envenomation of mice. Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi / Hong Kong Academy of Medicine. 18: 40-5. PMID 22302910  0.06
2001 Wang ML, Yung WK, Royce ME, Schomer DF, Theriault RL. Capecitabine for 5-fluorouracil-resistant brain metastases from breast cancer. American Journal of Clinical Oncology. 24: 421-4. PMID 11474279 DOI: 10.1097/00000421-200108000-00026  0.059
2011 Iwamoto FM, Lamborn KR, Kuhn JG, Wen PY, Yung WK, Gilbert MR, Chang SM, Lieberman FS, Prados MD, Fine HA. A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03. Neuro-Oncology. 13: 509-16. PMID 21377994 DOI: 10.1093/Neuonc/Nor017  0.058
2014 Wen PY, Cloughesy TF, Ellingson BM, Reardon DA, Fine HA, Abrey L, Ballman K, Bendszuz M, Buckner J, Chang SM, Prados MD, Pope WB, Gregory Sorensen A, van den Bent M, Yung WK. Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD). Neuro-Oncology. 16: vii36-47. PMID 25313237 DOI: 10.1093/neuonc/nou226  0.058
2002 Robins HI, Chang SM, Prados MD, Yung WK, Hess K, Schiff D, Greenberg H, Fink K, Nicolas K, Kuhn JG, Cloughesy T, Junck L, Mehta M. A phase II trial of thymidine and carboplatin for recurrent malignant glioma: a North American Brain Tumor Consortium Study. Neuro-Oncology. 4: 109-14. PMID 11916502 DOI: 10.1215/S1522851701000515  0.058
2002 Fuller GN, Hess KR, Rhee CH, Yung WK, Sawaya RA, Bruner JM, Zhang W. Molecular classification of human diffuse gliomas by multidimensional scaling analysis of gene expression profiles parallels morphology-based classification, correlates with survival, and reveals clinically-relevant novel glioma subsets. Brain Pathology (Zurich, Switzerland). 12: 108-16. PMID 11771519 DOI: 10.1111/j.1750-3639.2002.tb00427.x  0.058
2010 Norden AD, Raizer JJ, Abrey LE, Lamborn KR, Lassman AB, Chang SM, Yung WK, Gilbert MR, Fine HA, Mehta M, Deangelis LM, Cloughesy TF, Robins HI, Aldape K, Dancey J, et al. Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma. Journal of Neuro-Oncology. 96: 211-7. PMID 19562255 DOI: 10.1007/S11060-009-9948-7  0.058
2002 Zhou YH, Zheng JB, Gu X, Saunders GF, Yung WK. Novel PAX6 binding sites in the human genome and the role of repetitive elements in the evolution of gene regulation. Genome Research. 12: 1716-22. PMID 12421758 DOI: 10.1101/gr.188302  0.057
2011 de Groot JF, Lamborn KR, Chang SM, Gilbert MR, Cloughesy TF, Aldape K, Yao J, Jackson EF, Lieberman F, Robins HI, Mehta MP, Lassman AB, Deangelis LM, Yung WK, Chen A, et al. Phase II study of aflibercept in recurrent malignant glioma: a North American Brain Tumor Consortium study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 2689-95. PMID 21606416 DOI: 10.1200/Jco.2010.34.1636  0.057
2012 Theeler BJ, Yung WK, Fuller GN, De Groot JF. Moving toward molecular classification of diffuse gliomas in adults. Neurology. 79: 1917-26. PMID 23109653 DOI: 10.1212/WNL.0b013e318271f7cb  0.056
2004 Chang SM, Prados MD, Yung WK, Fine H, Junck L, Greenberg H, Robins HI, Mehta M, Fink KL, Jaeckle KA, Kuhn J, Hess K, Schold C. Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial. Cancer. 100: 1712-6. PMID 15073861 DOI: 10.1002/Cncr.20157  0.056
2004 See SJ, Levin VA, Yung WK, Hess KR, Groves MD. 13-cis-retinoic acid in the treatment of recurrent glioblastoma multiforme. Neuro-Oncology. 6: 253-8. PMID 15279718 DOI: 10.1215/S1152851703000607  0.055
2015 Hung IF, Zhang AJ, To KK, Chan JF, Li P, Wong TL, Zhang R, Chan TC, Chan BC, Wai HH, Chan LW, Fong HP, Hui RK, Kong KL, Leung AC, ... ... Yung W, et al. Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial. The Lancet. Infectious Diseases. PMID 26559482 DOI: 10.1016/S1473-3099(15)00354-0  0.055
2017 Wong E, Yang B, Du L, Ho WH, Lau C, Ke Y, Shing Chan Y, Yung WH, Wu EX. The multi-level impact of chronic intermittent hypoxia on central auditory processing. Neuroimage. PMID 28528846 DOI: 10.1016/J.Neuroimage.2017.05.036  0.055
2008 Corn BW, Moughan J, Knisely JP, Fox SW, Chakravarti A, Yung WK, Curran WJ, Robins HI, Brachman DG, Henderson RH, Mehta MP, Movsas B. Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118. International Journal of Radiation Oncology, Biology, Physics. 71: 71-8. PMID 18164829 DOI: 10.1016/j.ijrobp.2007.09.015  0.054
2000 Osoba D, Brada M, Prados MD, Yung WK. Effect of disease burden on health-related quality of life in patients with malignant gliomas. Neuro-Oncology. 2: 221-8. PMID 11265231 DOI: 10.1093/neuonc/2.4.221  0.054
2008 Groves MD, Glantz MJ, Chamberlain MC, Baumgartner KE, Conrad CA, Hsu S, Wefel JS, Gilbert MR, Ictech S, Hunter KU, Forman AD, Puduvalli VK, Colman H, Hess KR, Yung WK. A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies. Neuro-Oncology. 10: 208-15. PMID 18316473 DOI: 10.1215/15228517-2007-059  0.053
1999 Hess KR, Wong ET, Jaeckle KA, Kyritsis AP, Levin VA, Prados MD, Yung WK. Response and progression in recurrent malignant glioma. Neuro-Oncology. 1: 282-8. PMID 11550320 DOI: 10.1093/neuonc/1.4.282  0.053
2015 Liu Q, Liu Y, Li W, Wang X, Sawaya R, Lang FF, Yung WK, Chen K, Fuller GN, Zhang W. Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastoma. Acta Neuropathologica. PMID 26323991 DOI: 10.1007/S00401-015-1470-8  0.053
2003 Puduvalli VK, Hashmi M, McAllister LD, Levin VA, Hess KR, Prados M, Jaeckle KA, Yung WK, Buys SS, Bruner JM, Townsend JJ, Davis R, Sawaya R, Kyritsis AP. Anaplastic oligodendrogliomas: prognostic factors for tumor recurrence and survival. Oncology. 65: 259-66. PMID 14657600 DOI: 10.1159/000074479  0.052
2011 Wefel JS, Cloughesy T, Zazzali JL, Zheng M, Prados M, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Das A, et al. Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab. Neuro-Oncology. 13: 660-8. PMID 21558074 DOI: 10.1093/Neuonc/Nor024  0.052
2011 Lawrence YR, Wang M, Dicker AP, Andrews D, Curran WJ, Michalski JM, Souhami L, Yung WK, Mehta M. Early toxicity predicts long-term survival in high-grade glioma. British Journal of Cancer. 104: 1365-71. PMID 21487410 DOI: 10.1038/Bjc.2011.123  0.052
2015 Alexander BM, Galanis E, Yung WK, Ballman KV, Boyett JM, Cloughesy TF, Degroot JF, Huse JT, Mann B, Mason W, Mellinghoff IK, Mikkelsen T, Mischel PS, O'Neill BP, Prados MD, et al. Brain Malignancy Steering Committee clinical trials planning workshop: report from the Targeted Therapies Working Group. Neuro-Oncology. 17: 180-8. PMID 25165194 DOI: 10.1093/Neuonc/Nou154  0.052
2012 Giglio P, Dhamne M, Hess KR, Gilbert MR, Groves MD, Levin VA, Kang SL, Ictech SE, Liu V, Colman H, Conrad CA, Loghin M, de Groot J, Yung WK, Puduvalli VK. Phase 2 trial of irinotecan and thalidomide in adults with recurrent anaplastic glioma. Cancer. 118: 3599-606. PMID 22086614 DOI: 10.1002/Cncr.26663  0.052
2008 Puduvalli VK, Giglio P, Groves MD, Hess KR, Gilbert MR, Mahankali S, Jackson EF, Levin VA, Conrad CA, Hsu SH, Colman H, de Groot JF, Ritterhouse MG, Ictech SE, Yung WK. Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme. Neuro-Oncology. 10: 216-22. PMID 18314417 DOI: 10.1215/15228517-2007-060  0.052
2007 Groves MD, Puduvalli VK, Chang SM, Conrad CA, Gilbert MR, Tremont-Lukats IW, Liu TJ, Peterson P, Schiff D, Cloughesy TF, Wen PY, Greenberg H, Abrey LE, DeAngelis LM, Hess KR, ... ... Yung WK, et al. A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme. Journal of Neuro-Oncology. 81: 271-7. PMID 17031561 DOI: 10.1007/S11060-006-9225-Y  0.052
2021 Du L, Xu L, Liang T, Wing YK, Ke Y, Yung WH. Progressive Pontine-Medullary Dysfunction Leads to REM Sleep Behavior Disorder Symptoms in a Chronic Model of Parkinson's Disease. Nature and Science of Sleep. 13: 1723-1736. PMID 34675721 DOI: 10.2147/NSS.S328365  0.052
2010 Raizer JJ, Abrey LE, Lassman AB, Chang SM, Lamborn KR, Kuhn JG, Yung WK, Gilbert MR, Aldape KA, Wen PY, Fine HA, Mehta M, Deangelis LM, Lieberman F, Cloughesy TF, et al. A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy. Neuro-Oncology. 12: 95-103. PMID 20150372 DOI: 10.1093/Neuonc/Nop015  0.051
2003 Lang FF, Bruner JM, Fuller GN, Aldape K, Prados MD, Chang S, Berger MS, McDermott MW, Kunwar SM, Junck LR, Chandler W, Zwiebel JA, Kaplan RS, Yung WK. Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 21: 2508-18. PMID 12839017 DOI: 10.1200/Jco.2003.21.13.2508  0.051
2004 Wang LE, Bondy ML, Shen H, El-Zein R, Aldape K, Cao Y, Pudavalli V, Levin VA, Yung WK, Wei Q. Polymorphisms of DNA repair genes and risk of glioma. Cancer Research. 64: 5560-3. PMID 15313891 DOI: 10.1158/0008-5472.Can-03-2181  0.051
2002 Groves MD, Puduvalli VK, Hess KR, Jaeckle KA, Peterson P, Yung WK, Levin VA. Phase II trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 1383-8. PMID 11870183  0.05
2006 Wen PY, Yung WK, Lamborn KR, Dahia PL, Wang Y, Peng B, Abrey LE, Raizer J, Cloughesy TF, Fink K, Gilbert M, Chang S, Junck L, Schiff D, Lieberman F, et al. Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 4899-907. PMID 16914578 DOI: 10.1158/1078-0432.Ccr-06-0773  0.05
2020 Mak HK, Yung JSY, Weinreb RN, Ng SH, Cao X, Ho TYC, Ng TK, Chu WK, Yung WH, Choy KW, Wang CC, Lee TL, Leung CK. MicroRNA-19a-PTEN Axis Is Involved in the Developmental Decline of Axon Regenerative Capacity in Retinal Ganglion Cells. Molecular Therapy. Nucleic Acids. 21: 251-263. PMID 32599451 DOI: 10.1016/j.omtn.2020.05.031  0.05
2013 Weller M, Yung WK. Angiogenesis inhibition for glioblastoma at the edge: beyond AVAGlio and RTOG 0825. Neuro-Oncology. 15: 971. PMID 23864129 DOI: 10.1093/neuonc/not106  0.05
2015 Bin Abd Razak HR, Yung WY. Postoperative Delirium in Patients Undergoing Total Joint Arthroplasty: A Systematic Review. The Journal of Arthroplasty. PMID 25818653 DOI: 10.1016/j.arth.2015.03.012  0.049
2006 Cloughesy TF, Wen PY, Robins HI, Chang SM, Groves MD, Fink KL, Junck L, Schiff D, Abrey L, Gilbert MR, Lieberman F, Kuhn J, DeAngelis LM, Mehta M, Raizer JJ, ... Yung WK, et al. Phase II trial of tipifarnib in patients with recurrent malignant glioma either receiving or not receiving enzyme-inducing antiepileptic drugs: a North American Brain Tumor Consortium Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 3651-6. PMID 16877733 DOI: 10.1200/Jco.2006.06.2323  0.048
2012 Vivanco I, Robins HI, Rohle D, Campos C, Grommes C, Nghiemphu PL, Kubek S, Oldrini B, Chheda MG, Yannuzzi N, Tao H, Zhu S, Iwanami A, Kuga D, Dang J, ... ... Yung WK, et al. Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors. Cancer Discovery. 2: 458-71. PMID 22588883 DOI: 10.1158/2159-8290.Cd-11-0284  0.048
2008 Chang SM, Lamborn KR, Kuhn JG, Yung WK, Gilbert MR, Wen PY, Fine HA, Mehta MP, DeAngelis LM, Lieberman FS, Cloughesy TF, Robins HI, Abrey LE, Prados MD. Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor Consortium. Neuro-Oncology. 10: 631-42. PMID 18559968 DOI: 10.1215/15228517-2008-021  0.048
2004 Puduvalli VK, Yung WK, Hess KR, Kuhn JG, Groves MD, Levin VA, Zwiebel J, Chang SM, Cloughesy TF, Junck L, Wen P, Lieberman F, Conrad CA, Gilbert MR, Meyers CA, et al. Phase II study of fenretinide (NSC 374551) in adults with recurrent malignant gliomas: A North American Brain Tumor Consortium study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 4282-9. PMID 15514370 DOI: 10.1200/Jco.2004.09.096  0.048
2011 Siker ML, Wang M, Porter K, Nelson DF, Curran WJ, Michalski JM, Souhami L, Chakravarti A, Yung WK, Delrowe J, Coughlin CT, Mehta MP. Age as an independent prognostic factor in patients with glioblastoma: a Radiation Therapy Oncology Group and American College of Surgeons National Cancer Data Base comparison. Journal of Neuro-Oncology. 104: 351-6. PMID 21221714 DOI: 10.1007/s11060-010-0500-6  0.048
2000 Fine HA, Figg WD, Jaeckle K, Wen PY, Kyritsis AP, Loeffler JS, Levin VA, Black PM, Kaplan R, Pluda JM, Yung WK. Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 18: 708-15. PMID 10673511 DOI: 10.1200/jco.2000.18.4.708  0.047
2000 Yung WK, Albright RE, Olson J, Fredericks R, Fink K, Prados MD, Brada M, Spence A, Hohl RJ, Shapiro W, Glantz M, Greenberg H, Selker RG, Vick NA, Rampling R, et al. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. British Journal of Cancer. 83: 588-93. PMID 10944597 DOI: 10.1054/Bjoc.2000.1316  0.047
2016 Ceccarelli M, Barthel FP, Malta TM, Sabedot TS, Salama SR, Murray BA, Morozova O, Newton Y, Radenbaugh A, Pagnotta SM, Anjum S, Wang J, Manyam G, Zoppoli P, Ling S, ... ... Yung WK, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 164: 550-563. PMID 26824661 DOI: 10.1016/J.Cell.2015.12.028  0.045
2001 Kunschner LJ, Kuttesch J, Hess K, Yung WK. Survival and recurrence factors in adult medulloblastoma: the M.D. Anderson Cancer Center experience from 1978 to 1998. Neuro-Oncology. 3: 167-73. PMID 11465397 DOI: 10.1093/Neuonc/3.3.167  0.045
2015 Wun YT, Lam TP, Lam KF, Ho PL, Yung WH. Are There Differences in Antibiotic Use Between the Recent-Immigrants from Mainland China and the Local-Born in Hong Kong? Journal of Immigrant and Minority Health / Center For Minority Public Health. 17: 1177-84. PMID 24969039 DOI: 10.1007/s10903-014-0060-5  0.044
1998 Chan SO, Wong KF, Chung KY, Yung WH. Changes in morphology and behaviour of retinal growth cones before and after crossing the midline of the mouse chiasm - A confocal microscopy study European Journal of Neuroscience. 10: 2511-2522. PMID 9767382 DOI: 10.1046/j.1460-9568.1998.00257.x  0.043
2003 Jaeckle KA, Hess KR, Yung WK, Greenberg H, Fine H, Schiff D, Pollack IF, Kuhn J, Fink K, Mehta M, Cloughesy T, Nicholas MK, Chang S, Prados M. Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 21: 2305-11. PMID 12805331 DOI: 10.1200/JCO.2003.12.097  0.043
2006 Prados MD, Lamborn K, Yung WK, Jaeckle K, Robins HI, Mehta M, Fine HA, Wen PY, Cloughesy T, Chang S, Nicholas MK, Schiff D, Greenberg H, Junck L, Fink K, et al. A phase 2 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study. Neuro-Oncology. 8: 189-93. PMID 16533878 DOI: 10.1215/15228517-2005-010  0.043
2015 Penas-Prado M, Hess KR, Fisch MJ, Lagrone LW, Groves MD, Levin VA, De Groot JF, Puduvalli VK, Colman H, Volas-Redd G, Giglio P, Conrad CA, Salacz ME, Floyd JD, Loghin ME, ... ... Yung WK, et al. Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma. Neuro-Oncology. 17: 266-73. PMID 25239666 DOI: 10.1093/Neuonc/Nou155  0.042
2011 Yung WK. New impact factor number reflects sustained and enhanced growth. Neuro-Oncology. 13: 925. PMID 21852428 DOI: 10.1093/neuonc/nor128  0.042
2009 Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Huang J, Zheng M, Cloughesy T. Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 4733-40. PMID 19720927 DOI: 10.1200/Jco.2008.19.8721  0.042
2014 Hamza MA, Mandel JJ, Conrad CA, Gilbert MR, Yung WK, Puduvalli VK, DeGroot JF. Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma. Journal of Neuro-Oncology. 119: 135-40. PMID 24803001 DOI: 10.1200/Jco.2013.31.15_Suppl.2042  0.04
2011 Clarke JL, Ennis MM, Yung WK, Chang SM, Wen PY, Cloughesy TF, Deangelis LM, Robins HI, Lieberman FS, Fine HA, Abrey L, Gilbert MR, Mehta M, Kuhn JG, Aldape KD, et al. Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma? Neuro-Oncology. 13: 1118-24. PMID 21813511 DOI: 10.1093/Neuonc/Nor110  0.04
2004 Leung CK, Yung WH, Ng AC, Woo J, Tsang MK, Tse KK. Evaluation of scanning resolution on retinal nerve fiber layer measurement using optical coherence tomography in normal and glaucomatous eyes. Journal of Glaucoma. 13: 479-85. PMID 15534473 DOI: 10.1097/01.ijg.0000138205.99424.24  0.04
2015 Chang MH, Sandborn P, Pecht M, Yung WKC, Wang W. A return on investment analysis of applying health monitoring to LED lighting systems Microelectronics Reliability. 55: 527-537. DOI: 10.1016/J.Microrel.2015.01.009  0.039
2008 Lamborn KR, Yung WK, Chang SM, Wen PY, Cloughesy TF, DeAngelis LM, Robins HI, Lieberman FS, Fine HA, Fink KL, Junck L, Abrey L, Gilbert MR, Mehta M, Kuhn JG, et al. Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas. Neuro-Oncology. 10: 162-70. PMID 18356283 DOI: 10.1215/15228517-2007-062  0.039
2013 Alexander BM, Wen PY, Trippa L, Reardon DA, Yung WK, Parmigiani G, Berry DA. Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2. Neuro-Oncology. 15: 972-8. PMID 23857706 DOI: 10.1093/neuonc/not088  0.039
2008 Prados MD, Yung WK, Wen PY, Junck L, Cloughesy T, Fink K, Chang S, Robins HI, Dancey J, Kuhn J. Phase-1 trial of gefitinib and temozolomide in patients with malignant glioma: a North American brain tumor consortium study. Cancer Chemotherapy and Pharmacology. 61: 1059-67. PMID 17694310 DOI: 10.1007/s00280-007-0556-y  0.039
2010 Gilbert MR, Gonzalez J, Hunter K, Hess K, Giglio P, Chang E, Puduvalli V, Groves MD, Colman H, Conrad C, Levin V, Woo S, Mahajan A, de Groot J, Yung WK. A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma. Neuro-Oncology. 12: 1167-72. PMID 20729242 DOI: 10.1093/Neuonc/Noq100  0.038
2012 Yung WK. The value of cell line validation. Neuro-Oncology. 14: 675. PMID 22669103 DOI: 10.1093/neuonc/nos132  0.038
2007 Loghin ME, Prados MD, Wen P, Junck L, Lieberman F, Fine H, Fink KL, Metha M, Kuhn J, Lamborn K, Chang SM, Cloughesy T, DeAngelis LM, Robins IH, Aldape KD, ... Yung WK, et al. Phase I study of temozolomide and irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: a north american brain tumor consortium study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 7133-8. PMID 18056194 DOI: 10.1158/1078-0432.Ccr-07-0874  0.037
2001 Mehta M, Yung WK, Bullard D, Barger G, Choucair A, Gillin M, Grossman S, Guha A, Hammond ME, Michalski J, Prados M, Provins S, Scott C, Zamorano L. Radiation Therapy Oncology Group. Research Plan 2002-2006. Brain Tumor Committee. International Journal of Radiation Oncology, Biology, Physics. 51: 11-8. PMID 11641010  0.037
2011 Walbert T, Gilbert MR, Groves MD, Puduvalli VK, Yung WK, Conrad CA, Bobustuc GC, Colman H, Hsu SH, Bekele BN, Qiao W, Levin VA. Combination of 6-thioguanine, capecitabine, and celecoxib with temozolomide or lomustine for recurrent high-grade glioma. Journal of Neuro-Oncology. 102: 273-80. PMID 20652724 DOI: 10.1200/Jco.2010.28.15_Suppl.2057  0.037
2006 Groves MD, Puduvalli VK, Conrad CA, Gilbert MR, Yung WK, Jaeckle K, Liu V, Hess KR, Aldape KD, Levin VA. Phase II trial of temozolomide plus marimastat for recurrent anaplastic gliomas: a relationship among efficacy, joint toxicity and anticonvulsant status. Journal of Neuro-Oncology. 80: 83-90. PMID 16639492 DOI: 10.1007/S11060-006-9160-Y  0.037
2008 Filippi U, Brizzolara R, Venuti D, Cesarone A, Maritati VA, Podestà M, Yung WF, Bottaro LC, Orselli A, Chiappori A, Schiavo M, Caputo M, Bonassi S, Bagnasco M. Prevalence of post-partum thyroiditis in Liguria (Italy): an observational study. Journal of Endocrinological Investigation. 31: 1063-8. PMID 19246971  0.037
2013 Alexander BM, Wang M, Yung WK, Fine HA, Donahue BA, Tremont IW, Richards RS, Kerlin KJ, Hartford AC, Curran WJ, Mehta MP. A phase II study of conventional radiation therapy and thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806). Journal of Neuro-Oncology. 111: 33-9. PMID 23086432 DOI: 10.1007/s11060-012-0987-0  0.036
2014 Yung WK. Imaging endpoints in brain tumor clinical trials: proceedings of the January 30, 2014 Workshop. Introduction. Neuro-Oncology. 16: vii1. PMID 25313233 DOI: 10.1093/neuonc/nou291  0.036
2002 Ke LD, Shi YX, Yung WK. VEGF(121), VEGF(165) overexpression enhances tumorigenicity in U251 MG but not in NG-1 glioma cells. Cancer Research. 62: 1854-61. PMID 11912165  0.036
2008 Freire P, Vilela M, Deus H, Kim YW, Koul D, Colman H, Aldape KD, Bogler O, Yung WK, Coombes K, Mills GB, Vasconcelos AT, Almeida JS. Exploratory analysis of the copy number alterations in glioblastoma multiforme. Plos One. 3: e4076. PMID 19115005 DOI: 10.1371/Journal.Pone.0004076  0.035
2004 Yung WK. Current therapies for glioblastoma. Clinical Advances in Hematology & Oncology : H&O. 2: 572-3. PMID 16163238  0.035
2004 Prados MD, Yung WK, Jaeckle KA, Robins HI, Mehta MP, Fine HA, Wen PY, Cloughesy TF, Chang SM, Nicholas MK, Schiff D, Greenberg HS, Junck L, Fink KL, Hess KR, et al. Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: a North American Brain Tumor Consortium study. Neuro-Oncology. 6: 44-54. PMID 14769140 DOI: 10.1215/S1152851703000292  0.035
2010 Yung WK. The problem with cell phones...or maybe not. Neuro-Oncology. 12: 1087. PMID 20966155 DOI: 10.1093/neuonc/noq159  0.034
2015 Raizer JJ, Giglio P, Hu J, Groves M, Merrell R, Conrad C, Phuphanich S, Puduvalli VK, Loghin M, Paleologos N, Yuan Y, Liu D, Rademaker A, Yung WK, Vaillant B, et al. A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients. Journal of Neuro-Oncology. PMID 26476729 DOI: 10.1007/S11060-015-1958-Z  0.033
2012 Yung WK. New impact factor reflects increased quality. Neuro-Oncology. 14: 1115. PMID 22910299 DOI: 10.1093/neuonc/nos201  0.033
2002 Levin VA, Yung WK, Bruner J, Kyritsis A, Leeds N, Gleason MJ, Hess KR, Meyers CA, Ictech SA, Chang E, Maor MH. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas. International Journal of Radiation Oncology, Biology, Physics. 53: 58-66. PMID 12007942 DOI: 10.1016/S0360-3016(01)02819-X  0.033
2012 Lee EQ, Puduvalli VK, Reid JM, Kuhn JG, Lamborn KR, Cloughesy TF, Chang SM, Drappatz J, Yung WK, Gilbert MR, Robins HI, Lieberman FS, Lassman AB, McGovern RM, Xu J, et al. Phase I study of vorinostat in combination with temozolomide in patients with high-grade gliomas: North American Brain Tumor Consortium Study 04-03. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 6032-9. PMID 22923449 DOI: 10.1158/1078-0432.Ccr-12-1841  0.033
2008 Weller M, Yung WK. Bevacizumab--news from the fast lane? Neuro-Oncology. 10: 647. PMID 18776128 DOI: 10.1215/15228517-2008-074  0.032
2003 Levin VA, Hess KR, Choucair A, Flynn PJ, Jaeckle KA, Kyritsis AP, Yung WK, Prados MD, Bruner JM, Ictech S, Gleason MJ, Kim HW. Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 981-90. PMID 12631596  0.032
2006 Levin VA, Phuphanich S, Yung WK, Forsyth PA, Maestro RD, Perry JR, Fuller GN, Baillet M. Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation. Journal of Neuro-Oncology. 78: 295-302. PMID 16636750 DOI: 10.1007/s11060-005-9098-5  0.032
2014 Tang HT, Liu AL, Yung WK, Lo TK, Lau WL, Leung WC. Rebound increase in vaginal delivery for twins in a regional obstetric unit in Hong Kong. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. 126: 96-7. PMID 24721616 DOI: 10.1016/j.ijgo.2014.01.009  0.032
2010 Yung WK. Tumor stem cells, notch, and the news. Neuro-Oncology. 12: 115. PMID 20150377 DOI: 10.1093/neuonc/nop055  0.032
2009 Groves MD, Hess KR, Puduvalli VK, Colman H, Conrad CA, Gilbert MR, Weinberg J, Cristofanilli M, Yung WK, Liu TJ. Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma. Journal of Neuro-Oncology. 94: 229-34. PMID 19267183 DOI: 10.1007/S11060-009-9819-2  0.032
2012 Jing H, Shek L, Yung W, Jin X, Liu H. Dynamics of bacterial community composition during degradation of copepod fecal pellets Journal of Plankton Research. 34: 700-710. DOI: 10.1093/Plankt/Fbs043  0.032
2010 Raizer JJ, Abrey LE, Lassman AB, Chang SM, Lamborn KR, Kuhn JG, Yung WK, Gilbert MR, Aldape KD, Wen PY, Fine HA, Mehta M, Deangelis LM, Lieberman F, Cloughesy TF, et al. A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas. Neuro-Oncology. 12: 87-94. PMID 20150371 DOI: 10.1093/Neuonc/Nop017  0.03
2016 Zhou J, Zhang J, Lam SP, Mok V, Chan A, Li SX, Liu Y, Tang X, Yung WH, Wing YK. Mortality and Its Risk Factors in Patients with Rapid Eye Movement Sleep Behavior Disorder. Sleep. PMID 27306273 DOI: 10.5665/Sleep.6016  0.03
2013 Zhang C, Moore LM, Li X, Yung WK, Zhang W. IDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in glioma. Neuro-Oncology. 15: 1114-26. PMID 23877318 DOI: 10.1093/neuonc/not087  0.029
2015 Lau EY, Choi EW, Lai ES, Lau KN, Au CT, Yung WH, Li AM. Working memory impairment and its associated sleep-related respiratory parameters in children with obstructive sleep apnea. Sleep Medicine. 16: 1109-15. PMID 26298787 DOI: 10.1016/J.Sleep.2015.04.025  0.029
2009 Powis G, Ihle NT, Yung WK. Inhibiting PI-3-K for glioma therapy. Cell Cycle (Georgetown, Tex.). 8: 335. PMID 19164951  0.028
2013 Yung WK. Higher impact, wider influence. Neuro-Oncology. 15: 1113. PMID 23966014 DOI: 10.1093/neuonc/not135  0.028
2010 Yung WK. Impact Factor number reflects sustained high quality. Neuro-Oncology. 12: 893. PMID 20720000 DOI: 10.1093/neuonc/noq105  0.028
2014 Yung WK, Hui W, Chan YT, Lo TK, Tai SM, Sing C, Lam YY, Lo CM, Lau WL, Leung WC. Social obstetrics: non-local expectant mothers admitted through accident and emergency department in a public hospital in Hong Kong. Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi / Hong Kong Academy of Medicine. 20: 213-21. PMID 24812199 DOI: 10.12809/hkmj134181  0.028
2014 Chan YT, Ng VK, Yung WK, Lo TK, Leung WC, Lau WL. Relationship between intrapartum transperineal ultrasound measurement of angle of progression and head-perineum distance with correlation to conventional clinical parameters of labor progress and time to delivery. The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 1-6. PMID 25163523 DOI: 10.3109/14767058.2014.958459  0.028
2007 Scheurer ME, Etzel CJ, Liu M, El-Zein R, Airewele GE, Malmer B, Aldape KD, Weinberg JS, Yung WK, Bondy ML. Aggregation of cancer in first-degree relatives of patients with glioma. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 2491-5. PMID 18006942 DOI: 10.1158/1055-9965.Epi-07-0576  0.028
2000 Ke LD, Chen Z, Yung WK. A reliability test of standard-based quantitative PCR: exogenous vs endogenous standards. Molecular and Cellular Probes. 14: 127-35. PMID 10799275 DOI: 10.1006/mcpr.2000.0288  0.027
2007 Feigenbaum L, Martin S, Roy MN, Szekely B, Yung WC. Boca: an open-source RDF store for building Semantic Web applications. Briefings in Bioinformatics. 8: 195-200. PMID 17491005 DOI: 10.1093/bib/bbm017  0.026
2017 Zhou J, Zhang J, Lam SP, Chan JW, Mok V, Chan A, Li SX, Liu Y, Tang X, Yung WH, Wing YK. Excessive Daytime Sleepiness Predicts Neurodegeneration in Idiopathic REM Sleep Behavior Disorder. Sleep. PMID 28329332 DOI: 10.1093/Sleep/Zsx041  0.026
2015 Tang HT, Liu AL, Chan SY, Lau CH, Yung WK, Lau WL, Leung WC. Twin pregnancy outcomes after increasing rate of vaginal twin delivery: retrospective cohort study in a Hong Kong regional obstetric unit. The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 1-7. PMID 25893547 DOI: 10.3109/14767058.2015.1035640  0.025
2015 Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M, Morozova O, Robertson AG, Noushmehr H, Laird PW, Cherniack AD, et al. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. The New England Journal of Medicine. 372: 2481-98. PMID 26061751 DOI: 10.1056/Nejmoa1402121  0.025
2011 Pagarkar W, Gunny R, Saunders DE, Yung W, Rajput K. The bony cochlear nerve canal in children with absent or hypoplastic cochlear nerves. International Journal of Pediatric Otorhinolaryngology. 75: 764-73. PMID 21497917 DOI: 10.1016/j.ijporl.2011.02.017  0.024
2002 Kunschner LJ, Fine H, Hess K, Jaeckle K, Kyritsis AP, Yung WK. CI-980 for the treatment of recurrent or progressive malignant gliomas: national central nervous system consortium phase I-II evaluation of CI-980. Cancer Investigation. 20: 948-54. PMID 12449727 DOI: 10.1081/CNV-120005910  0.024
2013 Yung WK. Year brings higher impact factor, more submissions for Neuro-Oncology. Neuro-Oncology. 15: 1-3. PMID 23284031 DOI: 10.1093/neuonc/nos333  0.024
2012 Yung W, Haziza D. Comments on the paper "Bias-adjustment and calibration of jackknife variance estimator in the presence of non-response" Journal of Statistical Planning and Inference. 142: 2232-2240. DOI: 10.1016/j.jspi.2011.12.003  0.024
2011 Yung WKC, Liem HM, Choy HHS, Man YW. Correlating interconnect stress test and accelerated thermal cycling for accessing the reliabilities of high performance printed circuit boards Ieee Transactions On Components, Packaging and Manufacturing Technology. 1: 2005-2017. DOI: 10.1109/TCPMT.2011.2167323  0.022
2006 Colman H, Berkey BA, Maor MH, Groves MD, Schultz CJ, Vermeulen S, Nelson DF, Mehta MP, Yung WK. Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-beta for supratentorial glioblastoma: results of RTOG 9710. International Journal of Radiation Oncology, Biology, Physics. 66: 818-24. PMID 16887285 DOI: 10.1016/j.ijrobp.2006.05.021  0.021
2013 Chang S, Yung WK. New Neuro-Oncology Practice journal to launch in 2014. Neuro-Oncology. 15: 1277. PMID 24057884 DOI: 10.1093/neuonc/not160  0.02
2012 Liu AL, Yung WK, Yeung HN, Lai SF, Lam MT, Lai FK, Lo TK, Lau WL, Leung WC. Factors influencing the mode of delivery and associated pregnancy outcomes for twins: a retrospective cohort study in a public hospital. Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi / Hong Kong Academy of Medicine. 18: 99-107. PMID 22477732  0.02
2014 Lo TK, Yung WK, Lau WL, Law B, Lau S, Leung WC. Planned conservative management of placenta accreta - experience of a regional general hospital. The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 27: 291-6. PMID 23796273 DOI: 10.3109/14767058.2013.818118  0.02
2007 Grewal J, Dellinger CA, Yung WK. Fatal reactivation of hepatitis B with temozolomide. The New England Journal of Medicine. 356: 1591-2. PMID 17429098 DOI: 10.1056/NEJMc063696  0.018
2013 Yung WH, Yung LC, Hua LH. A study of the durability properties of waste tire rubber applied to self-compacting concrete Construction and Building Materials. 41: 665-672. DOI: 10.1016/j.conbuildmat.2012.11.019  0.018
2015 Yung WKC, Li G, Liem HM, Choy HS, Cai Z. Eye-friendly reduced graphene oxide circuits with nonlinear optical transparency on flexible poly(ethylene terephthalate) substrates Journal of Materials Chemistry C. 3: 11294-11299. DOI: 10.1039/c5tc02405f  0.018
2013 McGregor C, Ramsden M, Yung W. Slope rehabilitation and berth deepening of port Ports 2013: Success Through Diversification - Proceedings of the 13th Triennial International Conference. 640-649. DOI: 10.1061/97807784413067.066  0.018
2013 Yung WKA. Neuro-oncology: Past milestones and the journey ahead Neuro-Oncology. 15: 1453-1454. PMID 24174568 DOI: 10.1093/neuonc/not196  0.018
2013 Anderson MD, Theeler BJ, Penas-Prado M, Groves MD, Yung WK. Bevacizumab use in disseminated choroid plexus papilloma. Journal of Neuro-Oncology. 114: 251-3. PMID 23761024 DOI: 10.1007/s11060-013-1180-9  0.018
2001 Yung WK. Future directions for temozolomide therapy. Seminars in Oncology. 28: 43-6. PMID 11550138 DOI: 10.1016/S0093-7754(01)90070-3  0.017
2015 Lau EYY, Choi EWM, Lai ESK, Lau KNT, Au CT, Yung WH, Li AM. Working memory impairment and its associated sleep-related respiratory parameters in children with obstructive sleep apnea Sleep Medicine. 16: 1109-1115. DOI: 10.1016/j.sleep.2015.04.025  0.016
2000 Brada M, Yung WK. Clinical trial end points in malignant glioma: need for effective trial design strategy. Seminars in Oncology. 27: 11-9. PMID 10866345  0.016
2013 Chang MH, Pecht M, Yung WKC. Return on investment associated with PHM applied to an LED lighting system Phm 2013 - 2013 Ieee International Conference On Prognostics and Health Management, Conference Proceedings. DOI: 10.1109/ICPHM.2013.6621434  0.015
2015 Chan YT, Ng KS, Yung WK, Lo TK, Lau WL, Leung WC. Is intrapartum translabial ultrasound examination painless? The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 1-5. PMID 26699380 DOI: 10.3109/14767058.2015.1123241  0.015
2012 Yung WKC, Chan HK, So JHT, Wong DWC, Choi ACK, Yue TM. Environmental impact of two electrical products with reference to the energy-using products directive International Journal of Sustainable Engineering. 5: 86-90. DOI: 10.1080/19397038.2011.560689  0.014
2008 Yung W. Surgery for esophageal cancer: do age or incorrect data analysis have any impact on clinical outcome? The Journal of Thoracic and Cardiovascular Surgery. 135: 468-9; author reply . PMID 18242309 DOI: 10.1016/j.jtcvs.2007.07.070  0.013
2000 Osoba D, Brada M, Yung WK, Prados M. Health-related quality of life in patients treated with temozolomide versus procarbazine for recurrent glioblastoma multiforme. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 18: 1481-91. PMID 10735896 DOI: 10.1200/JCO.2000.18.7.1481  0.013
2012 Gomez-Manzano C, Jiang H, Alonso M, Yung WK, Fueyo J. Gene therapy. Handbook of Clinical Neurology. 104: 331-8. PMID 22230451 DOI: 10.1016/B978-0-444-52138-5.00021-9  0.013
2013 Wun YT, Lam TP, Lam KF, Ho PL, Yung WH. The public's perspectives on antibiotic resistance and abuse among Chinese in Hong Kong. Pharmacoepidemiology and Drug Safety. 22: 241-9. PMID 22915368 DOI: 10.1002/pds.3339  0.012
1999 Uhm JH, Yung WK. Neurologic Complications of Cancer Therapy. Current Treatment Options in Neurology. 1: 428-437. PMID 11096727  0.012
2015 Pachella LA, Kamiya-Matsuoka C, Lee EL, Olar A, Yung WK. Supratentorial extraventricular anaplastic ependymoma with extracranial metastasis. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 22: 605-7. PMID 25455735 DOI: 10.1016/j.jocn.2014.09.006  0.01
2013 Yung WK. From GWAS risk foci to glioma molecular subclass. Neuro-Oncology. 15: 513-4. PMID 23620433 DOI: 10.1093/neuonc/not061  0.01
2012 Yung WKA. A year of continued growth and success Neuro-Oncology. 14: 1-2. DOI: 10.1093/neuonc/nor225  0.01
2012 Yung WKC, Chan HK, Wong DWC, So JHT, Choi ACK, Yue TM. Eco-redesign of a personal electronic product subject to the energy-using product directive International Journal of Production Research. 50: 1411-1423. DOI: 10.1080/00207543.2011.571941  0.01
2012 Shafiq I, Chan YC, Wong NB, Yung WKC. Influence of small Sb nanoparticles additions on the microstructure, hardness and tensile properties of Sn-9Zn binary eutectic solder alloy Journal of Materials Science: Materials in Electronics. 23: 1427-1434. DOI: 10.1007/s10854-011-0608-2  0.01
2011 Sun SJ, Zhu JJ, Yung WKC. Studied on the microfluidic chip based on the kapton by excimer laser ablation Key Engineering Materials. 458: 81-86. DOI: 10.4028/www.scientific.net/KEM.458.81  0.01
2011 Gain AK, Chan YC, Yung WKC. Effect of additions of ZrO2 nano-particles on the microstructure and shear strength of Sn-Ag-Cu solder on Au/Ni metallized Cu pads Microelectronics Reliability. 51: 2306-2313. DOI: 10.1016/j.microrel.2011.03.042  0.01
2009 Yung WK. Quality of life: a fertile field for inquiry. Neuro-Oncology. 11: 241. PMID 19403802 DOI: 10.1215/15228517-2009-031  0.01
2008 Yung WK. Moving toward the next steps in angiogenesis therapy? Neuro-Oncology. 10: 939. PMID 18981258 DOI: 10.1215/15228517-2008-091  0.01
2008 Yung WK. Carrying Neuro-Oncology to a world that needs knowledge. Neuro-Oncology. 10: 1. PMID 18184773 DOI: 10.1215/15228517-2007-056  0.01
2007 Williams GJ, Macaskill P, Chan SF, Karplus TE, Yung W, Hodson EM, Craig JC. Comparative accuracy of renal duplex sonographic parameters in the diagnosis of renal artery stenosis: paired and unpaired analysis. Ajr. American Journal of Roentgenology. 188: 798-811. PMID 17312071 DOI: 10.2214/AJR.06.0355  0.01
2007 Yung WK, James CD. Mapping the future of Neuro-Oncology. Neuro-Oncology. 9: 1-2. PMID 17170381 DOI: 10.1215/15228517-2006-027  0.01
2001 Ajani J, Ettinger D, Kelsen DP, Hudis C, Kudelka A, Langer C, Pienta K, Safran H, Vokes EE, Yung WK. Radiation Therapy Oncology Group. Research Plan 2002-2006. Medical Oncology Committee. International Journal of Radiation Oncology, Biology, Physics. 51: 88-91. PMID 11641021  0.01
2000 Yung WK. Temozolomide in malignant gliomas. Seminars in Oncology. 27: 27-34. PMID 10866347  0.01
Hide low-probability matches.